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The ﬁeld of neurobionics offers hope to patients with sensory and motor impairment.
Blindness is a common cause of major sensory loss, with an estimated 39 million peopleAvailable online 15 November 2014
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worldwide suffering from total blindness in 2010. Potential treatment options include
bionic devices employing electrical stimulation of the visual pathways. Retinal stimulation
can restore limited visual perception to patients with retinitis pigmentosa, however loss of
retinal ganglion cells precludes this approach. The optic nerve, lateral geniculate nucleus
and visual cortex provide alternative stimulation targets, with several research groups
actively pursuing a cortically-based device capable of driving several hundred stimulating
electrodes. While great progress has been made since the earliest works of Brindley and
Dobelle in the 1960s and 1970s, signiﬁcant clinical, surgical, psychophysical, neurophysio-
logical, and engineering challenges remain to be overcome before a commercially-available
cortical implant will be realized. Selection of candidate implant recipients will require
assessment of their general, psychological and mental health, and likely responses to
visual cortex stimulation. Implant functionality, longevity and safety may be enhanced by
careful electrode insertion, optimization of electrical stimulation parameters and mod-
iﬁcation of immune responses to minimize or prevent the host response to the implanted
electrodes. Psychophysical assessment will include mapping the positions of potentially
several hundred phosphenes, which may require repetition if electrode performance
deteriorates over time. Therefore, techniques for rapid psychophysical assessment are
required, as are methods for objectively assessing the quality of life improvements0
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b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 352obtained from the implant. These measures must take into account individual differences
in image processing, phosphene distribution and rehabilitation programs that may be
required to optimize implant functionality. In this review, we detail these and other
challenges facing developers of cortical visual prostheses in addition to brieﬂy outlining
the epidemiology of blindness, and the history of cortical electrical stimulation in the
context of visual prosthetics.
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Neurobionics is the direct interfacing of electronic devices with
the nervous system. This interface may be exploited to facilitate
exogenous stimulation of the nervous system or for single and
multi-unit recording of neural activity. The signiﬁcant therapeu-
tic potential offered by neural recording is evident in recent
reports of multi-electrode prostheses implanted in the motor
cortex of humans and non-human primates, enabling thedextrous operation of a robotic arm and hands (Collinger et al.,
2013; Hochberg et al., 2012). This dexterity will undoubtedly be
greatly enhanced by the integration of sensory feedback (e.g.
mechanosensation), which has already been demonstrated in
macaques via microstimulation of somatosensory cortex (Berg
et al., 2013; O’Doherty et al., 2011; Tabot et al., 2013). Beyond the
experimental domain, electrical stimulation of the brain, spinal
cord and peripheral nerves via implanted electrodes is in use
clinically for the treatment of movement disorders (Williams and
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 3 53Okun, 2013), psychiatric disorders (Williams and Okun, 2013),
chronic pain (Plow et al., 2012), epilepsy (Bergey, 2013), neuro-
genic bladder (Lay and Das, 2012) and for the restoration of lost
sensory functions such as hearing (Carlson et al., 2012; Shepherd
et al., 2013). Currently, themost commercially successful sensory
prosthesis is the cochlear implant for treatment of neural deaf-
ness, of which the US National Institutes of Health reports there
were 324,200 recipients worldwide in December 2012 (National
Institute on Deafness and Other Communication Disorders,
2013). Restoration of visual perception to the blind or severely
vision impaired is another area of intense research effort and
two retinal bionic vision devices are now commercially available
(Weiland and Humayun, 2014). We brieﬂy review these and other
devices being developed for the restoration of functional vision
in blind individuals, before focusing on cortical visual prostheses
and the challenges facing developers of these devices. We
describe an implant currently being developed by the Monash
Vision Group which is currently in the preclinical testing phase.2. Epidemiology of blindness
Recent meta-analyses examining the global burden of blind-
ness and vision impairment highlight the scale of these
ongoing public health concerns. In two separate studies, the
total number of people with vision impairment in 2010 was
estimated at 191 million (Stevens et al., 2013) and 285 million
(Pascolini and Mariotti, 2012) globally, with the number of
those legally blind estimated at 32 and 39 million respec-
tively. The most recent of these studies found the most
common causes of blindness to be cataract (33%), uncorrected
refractive error (21%) and macular degeneration (7%) across
all regions studied (Stevens et al., 2013). As would be
expected, there is signiﬁcant regional variation in these
ﬁgures; in high-income regions including Western Europe,
Australasia (Australia and New Zealand), Asia-Paciﬁc and
North America, the most common causes are macular degen-
eration (16.1–19.5%), uncorrected refractive errors (14–14.1%)
and cataract (12.7–14.5%), with glaucoma and diabetic retino-
pathy comprising a further 14.5–16% combined (Bourne et al.,
2013). In Australia speciﬁcally, a 2005 study found age-related
macular degeneration (48%), glaucoma (14%), cataract (12%)
and diabetic retinopathy (11%) to be the most common
causes of blindness, with neuro-ophthalmic conditions
accounting for an additional 3% of cases (Taylor et al., 2005).
There were an estimated 530,000 vision impaired people in
Australia as of 2004, including 50,600 who were categorized as
legally blind (visual acuity of r6/60). This ﬁgure is predicted
to rise as a result of population ageing; Taylor et al. (2005,
2006) estimated that approximately 70,000 Australians would
be legally blind by 2014, and almost 90,000 by 2024 (Taylor
et al., 2005, 2006). Moreover, increasing rates of obesity-
related Type II diabetes (Shaw et al., 2010) will undoubtedly
contribute further to these ﬁgures.3. Economic impact
The direct health system costs in Australia for age-related
macular degeneration, glaucoma and cataract alone wereA$490 million in 2004. Indirect ﬁnancial costs relating to lost
income and carer costs for all visual impairment were
estimated at A$3.2 billion, exclusive of transfer costs includ-
ing lost tax revenue and the expenditure related to carer and
welfare payments, which were estimated at A$850 million
(Taylor et al., 2006). Visual impairment has been associated
with a 2.3 fold increase in mortality (McCarty et al., 2001) and
the costs speciﬁc to loss of well-being due to the impact of
disease and premature mortality have been estimated using
daily adjusted life years (DALY) at A$4.8 billion (Taylor et al.,
2006).4. Treatment options for blindness
4.1. Biological therapies
While not a major focus of this review, biological therapies
represent a promising suite of existing and emerging ther-
apeutic options for blindness caused by retinal disease. Gene
replacement therapy (McClements and MacLaren, 2013; Petrs-
Silva and Linden, 2014), modulation of ocular autoimmune
responses (Ambati et al., 2013; Buschini et al., 2011; Rieck,
2013), transplantation of stem cells, photoreceptor precursor
cells or bioengineered sheets of retinal tissue (Barber et al.,
2013; Fernandez-Robredo et al., 2014; Pearson, 2014) plus
intraocular administration of neurotrophic, anti-angiogenic,
intraocular pressure-lowering and antioxidant agents (Zarbin
et al., 2013) are all techniques that are either currently in use,
at clinical trial stage or being investigated in the laboratory.
4.2. Sensory substitution
Among the rehabilitative options available to the blind,
sensory substitution is a concept that has been explored
extensively. Sensory substitution operates on the principle of
replacing input from a lost sensory organ with an artiﬁcial
sensor, with the output of that sensor redirected to the input
of one or more remaining senses. A simple example of
sensory substitution is the mobility cane, wherein a repre-
sentation of the blind user's physical environment is
obtained via a tactile method (Bach-y-Rita and Kercel, 2003).
The representation of visual information by a tactile system
was suggested in the late 19th century by Noiszewski,
(Collins, 1971) with practical implementations of vibro- or
electrotactile stimulation of the back, abdomen, ﬁngertips
and tongue demonstrated by Bach-y-Rita and others over the
last 50 years (Bach-y-Rita et al., 1969, 1998; Collins, 1971;
Deroy and Auvray, 2012; Loomis, 2010). Alternatives to the
tactile approach include encoding visual information into
audible signals (Capelle et al., 1998; Hanneton et al., 2010;
Loomis, 2010; Meijer, 1992). Such devices have shown great
promise, however their uptake has been limited and devel-
opment is ongoing (Loomis, 2010; Reich et al., 2012).
4.3. Visual prostheses
Another approach to vision rehabilitation involves the gen-
eration of functionally useful visual perception by direct
electrical stimulation of the visual pathway (Fig. 1).
Fig. 1 – Graphical depiction of the visual pathways and
electrical stimulation targets for developing a visual
prosthesis. Small arrays of electrodes can be implanted
epiretinally, subretinally or suprachoroidally to stimulate
retinal ganglion cells and generate phosphenes. Similarly,
the axons of these cells can be stimulated as they pass along
the optic nerve, using “cuff-style” electrodes. The lateral
geniculate nucleus can be accessed using conventional
deep-brain stimulation electrodes, or newer-generation
devices incorporating a “tuft” of microelectrodes. Lastly, the
visual cortex may be stimulated directly using surface (not
shown) or penetrating microelectrodes.
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 354The application of such stimulation relies on three phy-
siologic principles (Maynard, 2001):1. Light can be replaced by electric current to stimulate the
perception of vision.2. Blindness due to retinal degeneration does not affect
signal transmission from the retinal ganglion cells
through the visual pathways.3. Electrical stimulation of the visual pathways and visual
cortex can elicit visual percepts in blind subjects.
Volta (1800) was among the ﬁrst to describe the visual
percepts, or phosphenes resulting from electrical stimulation
of the eye. In the two centuries since this observation,
countless experiments on both animals and humans have
conﬁrmed that electrical stimulation of the major anatomical
landmarks in the human visual pathway produces phos-
phenes of varying character.4.3.1. Retinal
Retinal stimulation has been covered extensively in the recent
literature, and the reader is directed to reviews by Shepherd
et al. (2013), Guenther et al. (2012), Ong and da Cruz (2012),
Fernandes et al. (2012), Theogarajan (2012) and Merabet (2011)
for additional details. Brieﬂy, visual prostheses based onelectrical stimulation of surviving populations of retinal gang-
lion cells have progressed substantially in recent years. Retinal
stimulation takes advantage of the signiﬁcant visual informa-
tion processing that occurs not only in the retina itself (Freeman
et al., 2011), but also the lateral geniculate nucleus (Cudeiro and
Sillito, 2006; Wiesel and Hubel, 1966).
Electrical stimulation of the retina may be achieved via
placement of epiretinal, subretinal, or suprachoroidal stimu-
lating electrode arrays. One such device, the Argus II epir-
etinal implant developed by Second Sight (Sylmar, California,
USA), has recently obtained regulatory approval for market-
ing in Europe and the United States. The Argus II is based on a
60-electrode array and a spectacles-mounted digital camera.
Clinical trials of the device have shown improved reading (da
Cruz et al., 2013) and motion detection (Dorn et al., 2013)
abilities in many recipients.
A variety of other implant designs are in development
worldwide. Stingl et al. (2013) recently described the clinical
trial results of a subretinal array (Alpha IMS) incorporating 1500
embedded photodiodes and matching stimulating electrodes.
In this device, incoming light is received by photodiodes, the
signals from which are then processed and ampliﬁed before
being sent to matching electrodes. The combination of photo-
diodes and electrodes therefore provides point-to-point stimu-
lus of retinal bipolar cells, eliminating the need for an external
camera and permitting object tracking via saccadic eye move-
ments. The device was trialed on 9 patients with retinitis
pigmentosa (n¼8) and cone-rod dystrophy (n¼1), resulting in
light perception by 8 patients with one excluded due to
complications during the implantation procedure (Stingl
et al., 2013). Functionally, the results were variable, with 7/8
patients able to localize a light source, 5/8 able to detect motion
and grating acuity testing able to be performed in 6/8 recipi-
ents. The device was recently approved for marketing in the
European Union (Retina Implant AG, 2014).
Whilst Alpha IMS is wirelessly powered via a subdermal
coil behind the ear that is tethered to the implant (Stingl
et al., 2013), Chow et al. (2004) recently described an alter-
native photodiode-based array with 5000 stimulating ele-
ments that is powered by incident light. This device,
referred to by its developers as the “Artiﬁcial Silicon Retina”
(ASR), has undergone limited clinical trials (Chow et al., 2010).
Bionic Vision Australia is also developing a suprachoroidal
retinal implant. In the popular press, the group recently
reported on the ﬁrst human implantation of a 24-electrode
prototype device (Bionic Vision Australia, 2012), with devel-
opment and testing of improved devices ongoing (Villalobos
et al., 2013).
4.3.2. Optic nerve
Veraart et al. (1998) were the ﬁrst to attempt electrical
stimulation of the optic nerve as a basis upon which to
develop a visual prosthesis. The method can be applied in
blind patients with surviving retinal ganglion cells and/or an
intact optic nerve, and was initially trialed on a 59-year old
female with retinitis pigmentosa (Veraart et al., 1998). After
demonstrating that phosphenes could be reproducibly eli-
cited at safe stimulation currents, the group developed a
computational model that could predict the location and size
of percepts as a function of stimulus parameters (Delbeke
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 3 55et al., 2003). With sufﬁcient training, recipients could recog-
nize and orient complex shapes (Brelen et al., 2005; Veraart
et al., 2003) and perform object localization, discrimination
and grasping (Duret et al., 2006). Phosphenes could be elicited
in all four visual ﬁeld quadrants, although they were irregu-
larly distributed and subtended a relatively narrow portion of
the horizontal ﬁeld (Delbeke et al., 2003). The surgical tech-
nique was relatively simple, with the ﬁrst patient receiving an
implant consisting of a four-electrode, non-penetrating sili-
con cuff implanted around the optic nerve, accessed via a
pterional craniotomy and a trans-Sylvian approach (Veraart
et al., 1998). The second recipient received an intraorbital
implant, which also produced phosphenes although it was
noted that higher stimulation currents were required, most
likely due to the impedance of the dural sheath that lay
between the electrodes and the nerve itself (Brelen et al.,
2006). Veraart's group are continuing testing of their device
(Brelen et al., 2010), and have since been joined by two others
developing optic nerve prostheses using electrodes stimulat-
ing either the optic nerve or the optic disk (Lu et al., 2013;
Sakaguchi et al., 2009; Wu et al., 2010).
4.3.3. Lateral geniculate nucleus
The lateral geniculate nucleus (LGN) is considered a favorable
stimulation target due to its compact dimensions, retinotopic
organization and the physical separation of pathways speciﬁc
to color and motion (Mullen et al., 2008; Wiesel and Hubel,
1966). The proximity of the LGN to structures targeted
surgically for pain control and movement disorders resulted
in reports of visual phenomena experienced during thalamicTable 1 – List of institutions known to us, who report plans to
L
Monash University University of Illinois
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relevant
publications
Brunton et al. (2012),
Lowery (2013), and
Wang et al. (2013)
Lane et al. (2012), Rush et a
(2011), Srivastava et al. (200
and Troyk et al. (2005)
Web Address http://www.monash.
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http://neural.iit.edu/researc
icvp/
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total # of
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e Estimated from the microphotograph in (Coulombe et al., 2007), no depstimulation procedures over three decades ago. Some of
these reports were published by Marg and Driessen (1965),
with their patients describing highly complex visual phenom-
ena during deep brain stimulation. In a recent macaque study
however, it was shown that simple, discrete visual percepts
could be elicited by microstimulation of LGN (Pezaris and
Reid, 2007). While in that study Pezaris et al. analyzed visual
saccades in response to LGN stimulation, Panetsos et al.
(2011) recently analyzed rat and rabbit cortical responses to
LGN stimulation, concluding that such stimulation could
generate visual cortical responses resembling those elicited
by natural vision. While much work remains to be done, both
groups report plans for further studies in support of devel-
oping a functionally useful visual prosthesis based on LGN
stimulation (Panetsos et al., 2011; Pezaris and Eskandar,
2009).
4.3.4. Geniculo-calcarine tract (optic radiations)
Reports exist of complex visual percepts elicited by stimula-
tion of the optic radiations during neurosurgical procedures
(Chapanis et al., 1973; Marg and Driessen, 1965), however to
date there are no groups known to us for whom this site is a
stimulation target for developing a visual prosthesis.
4.3.5. Visual cortex and the case for a cortical implant
Primary visual cortex, or V1, is an area of the occipital lobe
that encompasses the buried portions of cortex in the
calcarine sulcus and its upper and lower banks, extending
posterolaterally to the occipital pole. The reported surface
area of V1 varies between 1400 and 6300 mm2, depending ondevelop a cortical visual prosthesis at the time of writing.
ead Institution
Universidad Miguel
Hernández
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2014; Stensaas et al., 1974), with approximately 67% of that
area buried inside the calcarine ﬁssure (Stensaas et al., 1974).
Most efferent ﬁbers from the LGN synapse with layer 4 of V1,
from which numerous connections to other layers within V1
and those of higher visual centers are made (Troncoso et al.,
2011). Human trials of visual cortex electrical stimulation
with both surface and penetrating electrodes have demon-
strated the viability of this brain region as a target for a visual
prosthesis (Dobelle, 2000; Schmidt et al., 1996). While no
cortical visual implant has obtained regulatory approval to
date, Dobelle did achieve limited commercial and functional
success with his system prior to his death in 2003 (Anon.,
2005; Dobelle, 2000).
The attractiveness of visual cortex as the stimulation site
for a visual prosthesis is based on several factors. Firstly the
large surface area of visual cortex and the cortical magniﬁca-
tion factor combine to render it more amenable to implanting
large numbers of electrodes in cortical areas subserving
central vision (Daniel and Whitteridge, 1961; Harvey and
Dumoulin, 2011), potentially offering a higher-resolution visual
experience than either LGN or retinal implants. Secondly, the
stereotactic implantation of small occipital cortical electrode
arrays is a relatively straightforward procedure compared to
implanting deep LGN electrodes or microarrays onto, or under
the retina. Lastly, the utility of direct cortical stimulation
extends to all causes of visual impairment in patients with
late blindness due to retinal or optic nerve disease or injury.
Cortical visual prosthesis research therefore has enormous
potential for future treatment of visual impairment, and three
research groups known to us report ongoing plans, either in
the scientiﬁc literature or via their institutional websites, to
develop a cortical visual prosthesis (Table 1). Many other
research groups are conducting research within the general
domain of neural prosthetics, much of which may translate to
a cortical visual prosthesis. A number of these studies are
covered throughout this review.5. A brief history of cortical electrical
stimulation and cortical visual prosthesis
development
Visual cortex electrical stimulation has a rich history span-
ning almost a century, beginning with the early 20th century
observations of Löwenstein and Borchardt (1918), who stimu-
lated the occipital cortex of soldiers with occipital bullet
wounds. Research involving such patients provided a wealth
of data, with Krause and Förster subsequently demonstrating
that stable, punctate phosphenes could be elicited by elec-
trical stimulation of occipital cortex (Förster, 1929; Krause,
1924; Krause and Schum, 1931). These studies also conﬁrmed
that the retinotopic map of visual cortex was roughly equiva-
lent to that proposed by Inouye and Holmes, who examined
visual ﬁeld defects of soldiers with occipital bullet wounds
and concluded that the occipital pole subserved central vision
(Glickstein and Whitteridge, 1987; Holmes and Lister, 1916).
After Penﬁeld's extensive mapping studies (Penﬁeld, 1947)
and Button and Putnam's rudimentary but groundbreaking
attempts to provide visual perception to four blind volunteers(Button and Putnam, 1962; Button, 1958), the ﬁrst attempt to
produce a genuinely functional visual prosthesis was made
by Brindley and Lewin (1968). Their implant was a signiﬁcant
advance on Button and Putnam's four stainless steel wires,
consisting of an array of eighty 1 mm2 platinum electrodes
embedded in a silicon substrate and molded to the recipient's
occipital cortex. These were tethered to a subcutaneously-
implanted set of radio receivers containing basic circuitry
that permitted wireless stimulation of individual electrodes
in the array. The recipient was able to perceive phosphenes
from stimulation of 39/80 electrodes, with the nature of
elicited percepts varying from discrete, clustered, diffuse
and elongated points of light. While the system was ulti-
mately of no practical use to the recipient, it demonstrated
that stimulation of visual cortex with a fully-implanted,
multi-electrode implant was feasible and could produce
visuotopically organized percepts. Moreover, it suggested that
with an increased number of electrodes and phosphenes,
providing the blind with useful visual perception via cortical
stimulation may be possible.
Brindley's success was followed by a signiﬁcant increase
in research effort towards the development of a cortical
visual prosthesis, with a number of other groups publishing
the results of experiments directed at visual prosthesis
development in subsequent years (Dobelle and Mladejovsky,
1974; Pollen, 1975; Talalla et al., 1974). Both Brindley and
Dobelle's groups separately progressed their implants, even-
tually demonstrating that phosphenes could be assembled
into simple patterns for the purpose of reading Braille
characters (Brindley and Rushton, 1974; Dobelle, 1974).
The goals of visual prosthesis designers at the time were
generally centered on providing the blind with the ability
to read text or to improve their level of independent mobility.
Brindley had previously determined that 50 favorably placed
phosphenes would be required to permit the reading of
idealized letterforms, however up to 600 would be required
for the reading of handwriting (Brindley, 1965). Dobelle was
less focused on reading and more so on mobility (Dobelle
et al., 1979a) and his group reported plans to implant 512
electrodes towards that goal (Dobelle et al., 1979a). Brindley
made no further reports on his visual prosthesis develop-
ment program after 1982 (Brindley, 1982), however Dobelle
continued development, incorporating a camera and minia-
turizing the system to the point of portability. With ongoing
improvements in the sophistication of computing hardware,
Dobelle's (2000) system was ultimately capable of providing
limited object recognition and mobility to one of its recipients
with only 21 phosphenes. Despite this, it was similar to
Brindley's device, based on an array of surface electrodes
that required currents up to several milliamperes to elicit
phosphenes (Brindley and Lewin, 1968). Aside from limiting
the minimum spacing between electrodes and therefore any
resultant phosphenes, these large currents also increased the
risk of seizures for implant recipients (Naumann, 2012), a
problem that had previously plagued other researchers in the
ﬁeld (Pudenz, 1993). A further disadvantage was the bulk of
the cabling that connected to the electrodes via a transcuta-
neous connector ﬁxed to the skull.
An alternative, intracortical microstimulation (ICMS) with
miniature penetrating electrodes had already been established
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number of studies provided clear evidence that primates could
detect ICMS of visual cortex at much lower current levels, also
using electrodes more closely-spaced than those of Brindley
and Dobelle (Bartlett et al., 1977; Bartlett and Doty, 1980; Doty,
1965). Intracortical microelectrodes were not benign however;
chronic implantations revealed astrocytic proliferation around
the electrode shank (Schmidt et al., 1976), and unbalanced or
excess charge delivery could damage both the electrodes and
neuronal tissue (Bartlett et al., 1977; Brummer et al., 1983).
A preliminary human study examining ICMS of visual
cortex was published in 1990, the results of which added
signiﬁcant impetus to the effort to develop a cortical visual
prosthesis (Bak et al., 1990). Bak et al. reported that three
sighted volunteers were able to perceive phosphenes from
ICMS at currents up to 100 times lower than those required by
surface stimulation. Moreover, the phosphenes were discri-
minable when stimulated by electrodes 700 mm apart (Bak
et al., 1990). Further work identifying thresholds of total
charge delivered and charge density, beyond which neuronal
damage could be expected to occur (McCreery et al., 1994),
supported the progression to a more systematic evaluation of
ICMS of visual cortex in a blind volunteer in 1996 (Schmidt
et al., 1996). A key ﬁnding from this study was that the
chronically blind subject, who was unable to perceive phos-
phenes from surface stimulation, perceived phosphenes from
ICMS in a similar manner to sighted volunteers in the
previous report (Schmidt et al., 1996).
While this study represents a milestone in the develop-
ment of a cortical visual prosthesis, signiﬁcant engineering,
surgical, biological and psychophysiological issues still
remained to be addressed before an implant ﬁt for human
use could be realized. In the period since, signiﬁcant work
has been undertaken in understanding and addressing
these problems, with the goal of developing a functional,
wirelessly-operated cortical visual prosthesis with stable
long-term performance and an acceptable safety proﬁle.6. Current challenges and potential solutions
6.1. Selection of potential recipients
The recent approval of Second Sight's Argus II retinal implant
in both the US and Europe, and Retina Implant AG's European
approval of the Alpha IMS implant represents a signiﬁcant
step forwards in the regulatory environment for visual
prostheses. Cortical devices remain experimental, however
one group recently reported plans to apply for US FDA
approval to proceed with human clinical trials (Lane et al.,
2012). Given the relatively uncertain outlook for the balance
of risk versus beneﬁt for cortical visual prostheses, great rigor
must be exercised in the preclinical testing and the recipient
selection process.
6.1.1. Suitability for a retinal implant
The choice of a cortical approach to prosthetic visual rehabi-
litation should only be made after careful screening for
residual retinal functioning, to determine possible suitability
for a retinal implant (Merabet et al., 2007). Screeningtechniques may include tests of residual vision and the
measurement of thresholds for light perception in response
to retinal electrical stimulation (Yanai et al., 2003); the
majority of potential cortical implant recipients will likely
be those with complete failure of both retinae or optic nerves,
in whom no responses to light will be observed.
Potential recipients of a cortical visual prosthesis will need
further assessment to determine the likelihood of success-
fully eliciting visuotopically ordered phosphenes via ICMS of
visual cortex.
6.1.2. Responses to electrical stimulation of visual cortex
In the normally-sighted, the functional development of visual
cortex is guided by the presence of both spontaneous (prior to
eye opening) and stimulated (after eye opening) retinal and
cortical activity (Espinosa and Stryker, 2012). In the absence
of visual input, the connectivity and architecture of visual
cortex are altered. While magnetic resonance imaging (MRI)
studies of the congenitally blind (CB) have shown preserva-
tion of geniculocalcarine tract ﬁber integrity (Schoth et al.,
2006; Zhang et al., 2012), reductions in the volume of the LGN,
geniculocalcarine tract and visual cortex (Ptito et al., 2008b;
Qin et al., 2013), increased thickness of primary visual cortex
(Anurova et al., 2014; Qin et al., 2013), and increased func-
tional connectivity between visual and non-visual cortices
(Collignon et al., 2013; Qin et al., 2013) are seen in this subject
group. From a functional perspective, this reorganization of
visual cortex is believed to reﬂect the process of sensory
cross-modal adaptation, in which visual cortex is recruited
for non-visual tasks, including Braille reading and auditory
processing (Burton et al., 2002; Collignon et al., 2013). Such
changes clearly have signiﬁcant implications for the selection
of potential visual prosthesis recipients, and the preoperative
evaluation of responses to visual cortical stimulation will be
an important component of the process.
Direct electrical stimulation of visual cortex in the pre-
operative setting is not feasible, however transcranial mag-
netic stimulation (TMS) is a tool that may offer a method for
noninvasively assessing potential cortical visual prosthesis
implant recipients prior to surgery. Previous studies of occi-
pital TMS in normally-sighted subjects have demonstrated
that it can elicit simple phosphenes (Marg, 1991; Merabet
et al., 2003), while in blind subjects the responses to TMS
differ between the early (EB) and late blind (LB). Gothe et al.
(2002) used TMS to stimulate the occipital cortex of blind
individuals subgrouped by the presence or absence of resi-
dual vision. Notably, no EB study participants without mem-
ory of vision reported phosphenes from occipital TMS. In the
remaining subjects, 60% (6/10) of those with residual vision
perceived phosphenes compared to 20% (2/10) of those with
no residual vision, and the lack of phosphene perception was
signiﬁcantly correlated to the time since blindness onset. In
another study, Kupers et al. (2006) stimulated the occipital
cortex of a group of blind subjects trained in the use of a
tongue-based tactile sensory substitution device. Impor-
tantly, no EB study participants experienced phosphenes in
response to occipital TMS, whereas 2/5 LB participants
reported phosphenes.
It remains unclear as to whether those who are unrespon-
sive to occipital TMS would also be unresponsive to ICMS of
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may experience phosphenes in response to either surface
(Brindley and Rushton, 1974) or intracortical (Button and
Putnam, 1962) stimulation of visual cortex, however the
diffuse nature of the percepts may severely limit their
application in a visual prosthesis. Moreover, the absence of
residual vision may also not be predictive of a poor response
to ICMS of visual cortex; a subject with a 22-year history of
blindness and no residual vision reported no phosphenes
from surface stimulation (Schmidt et al., 1996), whereas ICMS
elicited stable, punctate percepts consistent with those
described by sighted volunteers (Bak et al., 1990). TMS is
itself a fairly blunt instrument with relatively poor focality,
and it may be that the diffuse nature of TMS emulates that
derived from stimulation with cortical surface electrodes.
Further work is necessary to address these questions.
Further complicating the question of implant recipient
selection is the potential for occipital stimulation to disrupt
any cross-modal sensory adaptations upon which a potential
recipient's activities of daily living depend (Fernandez et al.,
2005). For example, previous work has demonstrated that
TMS over the occipital cortex of CB and EB subjects proﬁcient
in Braille can signiﬁcantly impair their reading accuracy
(Kupers et al., 2007). Other groups have reported that this
phenomenon may be speciﬁc to these groups only, with LB
subjects not experiencing the same degree of disruption
(Cohen et al., 1999). There is little data on whether repeated
stimulus to the visual cortex of a blind subject, demonstrat-
ing sensory cross-modal adaptation, may produce a more
permanent impairment of their adaptations. Such changes
would be of particular concern if a cortical implant were to
eventually fail, after which a return to the pre-implant
functional state would be required. Recent work showing
that normally-sighted individuals deprived of visual input
show rapid functional recruitment of visual cortex after 5
days of Braille training suggests that even in adulthood,
neuroplasticity is preserved to a level that supports relatively
rapid shifts in the functional organization of visual cortical
networks (Merabet et al., 2008). If such plasticity is preserved
in adult LB subjects, this may suggest that a return to pre-
study levels of cross-modal sensory adaptation may be
possible in the event of a persistent impairment resulting
from long-term visual cortical stimulation.
From another perspective, an established state of cross-
modal sensory adaptation may in fact impair the ability of an
implant to elicit simple phosphenes at all, in favor of phantom
perceptions related to extra-visual sensory cortices, e.g. touch
(Kupers et al., 2006; Merabet et al., 2007; Ptito et al., 2008a). More
research needs to be done to determine the impact of neuro-
plasticity on the likely performance of an implant in the long
term, or conversely any negative inﬂuence of the implant on
the recipients' adaptations to blindness.
6.1.3. General and psychological health
The implantation of penetrating cortical electrode arrays is a
major neurosurgical procedure. As with any surgery involving
the opening of the skull and intradural space, there is a
demonstrable risk of acute and longer-term complications
resulting in a poor surgical and clinical outcome. These risks
include but are not limited to postoperative hemorrhage,swelling, tissue infarction, infection, seizures and neurologi-
cal deﬁcits, each of which may delay or preclude progressing
to the implant testing stage (discussed in more detail in
Section 6.2).
A key component to minimizing these risks will be the
selection of candidate recipients in whom the burden of
comorbidities known to negatively impact on neurosurgical
outcomes is acceptably low. For example, the risk of post-
operative bleeding is increased by hypertension, diabetes and
coagulopathy (Seifman et al., 2011). Poor nutritional status
due to advanced age, malignancy or obesity may increase the
risk of infection (Walcott et al., 2012), and preoperative
screening for MRSA colonization may be helpful in avoiding
a complicated postoperative course in the event of infection
(Harrop et al., 2012). Patients with a history of epilepsy are
innately at greater risk of suffering postoperative seizures,
and should be excluded (Weiss and Post, 2011).
The complexity and experimental status of the implant
procedure and rehabilitation process dictates that obtaining
informed consent, for which a detailed discussion of surgical
risks is required, will need to be undertaken carefully to
ensure a thorough understanding by potential recipients. The
mental health and capacity of a potential recipient is there-
fore of paramount importance in this context, as it may
potentially impact on the treating physician's ability to
ensure that a truly informed consent can be obtained (Lane
et al., 2012; Merabet et al., 2007). Moreover, it may impact on
the perception of the soundness of potential recipients'
motivation to participate, or the likelihood of effective reha-
bilitation (Dagnelie, 2008; Merabet et al., 2007). Lane et al.
(2012) studied motivation as a core theme when surveying
potential implant recipients, noting that individual reasons
for wanting to pursue implant surgery included participation
in cutting-edge research, the more benevolent ideal of con-
tributing to the future development of visual prostheses, and
of course deriving personal beneﬁt through improved visual
perception.
Importantly, the likely beneﬁts of even limited visual
restoration to a blind individual are often under appreciated
by sighted individuals (Lane et al., 2012). Even rudimentary
prosthetic vision in the setting of profound blindness may
have signiﬁcant positive psychological and functional rami-
ﬁcations for a blind individual, contributing to reduced feel-
ings of isolation and depression (Dagnelie, 2008). Only a few
reproducible phosphenes may be required to improve an
individual's quality of life. For example, a recipient of the
Dobelle implant was able to navigate independently and read
letters on a Snellen chart with only 21 phosphenes at his
disposal (Dobelle, 2000). In the most simple of demonstra-
tions, the reported elation felt by blind volunteers stimulated
with only 4 occipital electrodes, in addition to their ability to
independently locate a light source (Button and Putnam,
1962), suggests that questions of what constitutes “accepta-
ble” performance by both recipients and treating physicians
alike, needs to be carefully balanced.
6.2. Postoperative care
Progression to functional testing of a cortical implant is
predicated on an uneventful implantation procedure and
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surgical outcomes will depend partly on careful selection of
implant recipients, for whom good general health will likely
be a pre-requisite. Beyond this, there is a paucity of data on
which to base ﬁrm statements about the risk of postoperative
complications in current-generation cortical visual prosthesis
recipients per se, however inferences can be made by draw-
ing from older studies, the general neurosurgical literature
and recent reports on neuroprostheses implanted for other
CNS disorders.
The works of Brindley and Dobelle provide historical
insights into the risks of cortical implant surgery, although
miniaturization of implant hardware, and improvements in
operative technique and infection prophylaxis probably ren-
der these of little contemporary relevance. Nonetheless,
recipients of implants from both groups reportedly suffered
implant-related infections (Naumann, 2012; Rushton et al.,
1989). More recent large-series reports describe infection
rates of 3.1% following the implantation of deep brain
stimulators (DBS) (Fenoy and Simpson, 2014), 3.5% for hydro-
cephalus shunts (Parker et al., 2014) and 2.3% for subdural
recording electrodes (Arya et al., 2013). While these ﬁgures are
more informative, several factors suggest that these studies
may overestimate the likely risk for future visual cortex
implant recipients. Firstly, shunt candidates often present
with comorbidities that increase their infection risk, while
subdural recording electrodes incorporate externalized wires
that provide a pathway for the intracranial migration of
bacteria. On the other hand, while deep brain stimulators
are fully implanted, DBS patients tend to be older (Fenoy and
Simpson, 2014), and full dural closure is not possible due to
the presence of lead wires connecting the electrode to the
subcutaneous stimulator hardware. Future cortical visual
prosthesis implants will likely be universally wireless in
operation, permitting full implantation, dural closure and
therefore a lower infection risk that we estimate to be 1–2%.
Standard infection prophylaxis will nonetheless be required,
including broad-spectrum and staphylococcus-speciﬁc
antibiotics.
Where symptomatic postoperative bleeding is concerned,
a prevalence of 0.8% has previously been reported for the
general neurosurgical population (Kalfas and Little, 1988),
which is consistent with the ﬁgure of 1.1% reported by Fenoy
and Simpson (2014) for intracerebral hemorrhage resulting
from DBS lead insertion. However, comparing the likely risk
of clinically signiﬁcant intracerebral hemorrhage resulting
from the insertion of DBS electrodes vs. cortical electrode
arrays is difﬁcult. A DBS electrode penetrates both cortical
and subcortical tissue, with tissue damage localized to the
penetration trajectory. In the case of cortical electrode arrays,
a greater cortical surface area is compromised, however using
tiled electrodes will permit the avoidance of large vessels.
Moreover, the electrodes in a cortical prosthesis will only
penetrate to 1.5–3.0 mm. We therefore consider that the ﬁgure
of 1.1% reported for DBS implantation is a reasonable estimate
of the likely risk of clinically signiﬁcant intracerebral hemor-
rhage resulting from cortical visual prosthesis implantation.
There is also a risk of extracerebral (extradural or sub-
dural) bleeding after neurosurgical procedures. For epileptic
patients undergoing implantation of subdural recordingelectrodes, Arya et al. (2013) reported that 3.53% of patients
in their systematic review required postoperative evacuation
of intracranial hemorrhage, the most common being sub-
dural. Importantly, the size of the grids in this review varied
greatly; Wong et al. (2009) reported grid size as an indepen-
dent risk factor for postoperative complications in subdural
grid surgery, reﬂecting the increased risk with greater surgical
exposure.
The craniotomy required for a cortical visual prosthesis
will be smaller than that required for large subdural grid
implantations. For example, one group report plans to
implant up to 650 electrodes across the dorsolateral surface
of the occipital pole, covering an area approximately 3 cm in
radius or approximately 7 cm2 (Srivastava et al., 2007). Our
group is planning for implantation of up to 500 electrodes
over an area covering approximately 9–10 cm2 (Lowery, 2013).
Taking into account the relatively small craniotomy required
for a cortical visual prosthesis, we estimate that the risk of
symptomatic postoperative extracerebral bleeding (e.g. sub-
dural/extradural) will be consistent with that of the general
neurosurgical population.
Postoperative cerebral edema and subsequent neurologi-
cal deﬁcit is another potential complication requiring careful
consideration. Fenoy and Simpson (2014) reported that 0.3%
(2/728) of DBS patients demonstrated evidence of postopera-
tive edema, localized to the electrode tip and causing only a
transient motor deﬁcit. Arya et al. (2013) reported a higher
prevalence of 2.4% for patients undergoing implantation of
subdural monitoring electrodes. The risk of postoperative
edema is increased by lengthy and/or forceful brain retrac-
tion, and intraoperative tissue ischemia, for example due to
venous hypertension (Weiss and Post, 2011). Moreover, as
described previously, the complication rate for subdural grid
electrodes is higher for large grids, and the area of exposed
cortex in visual cortical implant surgery will be relatively
small. We therefore estimate the likely risk to implant
recipients to be in the order of 1–2%, based on the existing
literature and the relative simplicity of the implant proce-
dure. Nonetheless, the risk of postoperative swelling after
visual cortical electrode array implantation will minimized by
the sparing use of brain retraction and unilateral implanta-
tion of electrodes. In the unlikely event of clinically relevant
postoperative cerebral edema, standard medical manage-
ment may include pharmacologic interventions such as
osmotic agents and steroids where required.
In summary, the risk of clinically signiﬁcant adverse
events following visual cortical implant surgery is likely to
be low. This statement is supported by the existing neuro-
surgical literature, as well as the growing number of reports
describing uneventful temporary (House et al., 2006; Waziri
et al., 2009) and longer-term (Collinger et al., 2013; Hochberg
et al., 2012) implantations of high-density electrode arrays
into human cerebral cortex.
A key non-surgical element to the postoperative care of
visual cortical implant recipients will be the provision of
ongoing, subject-speciﬁc psychological support. This
approach has been taken by other groups following implan-
tation of a cortical motor neuroprosthesis (Collinger et al.,
2014) and retinal visual prostheses (Peters et al., 2013). Both
groups describe the involvement of psychologists throughout
Fig. 2 – (a, b) Possible distribution of phosphenes from
cortical microstimulation of V1 alone (a) or in combination
with V2 and V3 (b).
Figure reproduced from (Srivastava et al., 2007) with
permission.
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cipants adjust to the ongoing demands of participating in a
high-proﬁle research project, along with ensuring outcome
expectations and wellbeing were carefully monitored
throughout. We anticipate this will become a standard ele-
ment in the postoperative management of cortical visual
prosthesis recipients also.
6.3. Implant assessment
6.3.1. Psychophysical testing
After implantation and recovery, a signiﬁcant amount of
testing will be required to establish the most effective
stimulation parameters for each individual electrode. Given
the large numbers of electrodes likely to be implanted, this
represents a formidable task; reports of lengthy phosphene
threshold testing procedures in implants with approximately
150 electrodes suggest that it has the potential to be an
arduous process (Naumann, 2012; Rushton and Brindley,
1977). Moreover, alterations in phosphene thresholds over
time (Davis et al., 2012) may require this process to be
repeated to ensure a consistent visual experience. Improved
tools to speed up the establishment of appropriate stimulus
parameters across large numbers of electrodes are required,
and these will support the long-term efﬁcacy of cortical visual
prostheses.
Beyond the establishment of appropriate stimulus para-
meters for reliable phosphene generation, the elicited per-
cepts also need to be integrated into a visuotopic map linking
cortical electrodes to phosphenes in visual space. The inher-
ent inter-individual variability in anatomical and visuotopical
arrangement of visual cortex, in addition to the potential for
long-term blindness to inﬂuence visual cortical functional
organization dictates that this process must be undertaken
on a per-recipient basis (Stronks and Dagnelie, 2011). More-
over, some mapping techniques, for example tracking eye
saccades to the location of remembered phosphenes (Bradley
et al., 2005; Dagnelie et al., 2003), may not be applicable in
blind individuals where the eye muscles do not function
normally. Pointing methods (Brelen et al., 2005; Brindley and
Lewin, 1968) have proven useful in the past for mapping of
phosphenes elicited by visual cortical and optic nerve stimu-
lation, although a relatively wide area of visual ﬁeld was
covered by phosphenes in both cases with an approximately
411 vertical141 horizontal distribution for the optic nerve
device (Brelen et al., 2005), and a similar distribution, albeit in
a single hemiﬁeld in Brindley's ﬁrst patient (Brindley and
Lewin, 1968).
The distribution of phosphenes elicited by intracortical
microstimulation will also depend on the extent of electrode
implantation across visual cortex. Whilst implantation of
penetrating electrodes within the anterior zone of medial
V1 may not be feasible due to the difﬁculty of access,
stimulation of peristriate cortices (V2/V3) can also elicit
phosphenes (Dobelle et al., 1979b). Moreover, these phos-
phenes may conform to alternate visuotopic maps, poten-
tially ﬁlling in gaps in the visual ﬁeld that would otherwise
exist when stimulating V1 only (Srivastava et al., 2007 [Fig. 2]).
Nonetheless, most phosphenes will likely be clustered near
the center of the visual ﬁeld, given that the occipital polerepresents the most likely implantation site (Lowery, 2013;
Srivastava et al., 2007). Precisely mapping such large numbers
of small, closely-spaced phosphenes will undoubtedly require
rapid, potentially automated techniques in order to generate
consistent maps.
The problem of phosphene maps moving proportionally
with eye saccades is well known (Brindley and Lewin, 1968;
Dobelle and Mladejovsky, 1974). Not only does this compli-
cate the generation of consistent phosphene maps, but it also
introduces a requirement for central gaze ﬁxation during
head turning, or sophisticated eye tracking technology to
ensure image stability during changes in eye position. Retinal
implants incorporating a light-sensitive electrode array may
circumvent this problem (Chow et al., 2004), as would an
intraocular camera (Hauer, 2009), which may possibly be
adapted for a cortical prosthesis. Importantly, such techni-
ques may only be useful in those subjects not demonstrating
signiﬁcant gaze instability or suffering from nystagmus
(Schneider et al., 2013).
6.3.2. Image processing
The work of Dobelle (2000) provided clear evidence that
preserved neuroplasticity in visual cortex can permit a blind
individual, who had an initially poor response to patterned
stimulation, to gradually recognize shapes, letters and features
in a relatively complex physical environment. According to
Dobelle (2000), a key factor in achieving this goal was increased
computing power, which permitted the use of more sophisti-
cated image processing algorithms providing enhanced edge
detection, whilst keeping frame rates at acceptable levels.
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hundred or more phosphenes (Lowery, 2013; Normann et al.,
2009; Srivastava et al., 2007), many more than were reported
by any previous cortical implant recipient (Brindley and
Lewin, 1968; Brindley et al., 1972; Brindley, 1982; Dobelle,
2000; Naumann, 2012). The manner in which visual imagery
is preprocessed prior to reconstruction with phosphenes is
therefore of great importance, and is a subject of ongoing
research.
Early studies of simulated phosphene vision used simple
perforated masks of varying density and “pixel” count, which
provide a crude estimate of the likely pattern of percepts
experienced by a cortical prosthesis recipient (Cha et al.,
1992a). This technique provides a model for many subse-
quent reports of simulated phosphene imagery, namely that
the phosphenated image is a grayscale, “downsampled”
version of the original, with multiple levels of brightness
allowable per pixel. Some more recent studies have added
irregularities in the distribution and character of percepts
including variable size, brightness, density, overlap and a
restricted spread of phosphenes across the visual ﬁeld to
more accurately estimate the perceptual experience (Chen
et al., 2009b; Srivastava et al., 2009). Nonetheless, the same
approach is essentially employed, wherein the resultant
image remains a downsampled version of the original, albeit
with phosphenes conforming to a more realistic electrode/
phosphene coordinate system.
Chen et al. (2009b) discussed in detail the likely implica-
tions of phosphene maps with poor resolution and contrast,
restricted ﬁelds of view, high eccentricity in the main phos-
phene ﬁeld, geometric distortions in images and other such
limitations for the rehabilitation of visual prosthesis recipi-
ents. While well-designed training programs may permit
recipients to work around or adapt to these limitations,
modiﬁcations or extensions to the basic idea of representing
imagery in an “intensity-based” (McCarthy et al., 2011) fash-
ion have been described that may minimize the functional
impact of the relatively poor quality of prosthetic vision. For
example, Parikh et al. (2013) used feature extraction algo-
rithms to identify the most relevant parts of an image, with a
blinking phosphene guiding prosthesis recipient's attention
to a particular part of the visual ﬁeld. The authors reported
improvements in object avoidance, reductions in head scan-
ning and more rapid object location with the use of cues. In a
similar fashion, Mohammadi et al. (2012) propose the use of a
range-ﬁnding algorithm to estimate the distance to objects,
which would be relayed to the prosthesis wearer using a
group of phosphenes reserved for this purpose.
The use of more advanced image processing techniques
derived from the ﬁeld of robotics may provide further
improvements in the way in which phosphenes are utilized
to represent the physical environment. For example, recogni-
tion of the ground plane to clearly identify unobstructed
areas when walking may permit better obstacle avoidance
(Lui et al., 2012; McCarthy et al., 2011). Object recognition and
location, particularly in complex environments, may be
improved by using symbolic or iconographic techniques akin
to those used in computer graphics (Lui et al., 2012). Facial
recognition in particular may beneﬁt from these techniques,
whereby simplistic representations of faces (Lui et al., 2012)could be assembled using far fewer phosphenes than would
be possible using an intensity-based method (Bradley et al.,
2005). Such techniques may be particularly useful in the case
of long-term phosphene dropout and map degradation,
allowing the available phosphenes to be used to maximal
effect. The choice by Brindley and Dobelle to present Braille
characters instead of conventional lettering could be consid-
ered a conceptually similar “repurposing” of a poor quality
phosphene map to maximize its utility (Brindley and
Rushton, 1974; Dobelle, 1974).
As demonstrated by the success of Dobelle's (2000) last
reported patient (in the scientiﬁc literature), the ongoing
development of image processing techniques applicable to
prosthetic vision should continue to provide improvements
in the likely outcomes of visual prosthesis recipients, both
cortical and retinal. Even further improvements will undoubt-
edly come from an improved understanding of the encoding
of the more complex features of imagery, such as color, form
and motion in visual cortex neurons, possibly offering a
richer visual experience (Normann et al., 2009). Moreover,
with reductions in the size of the stimulated neuron pool,
possibly via increases in the density of electrode arrays (e.g.
Wark et al., 2013), and a “bioinspired” approach to encoding
information into neuronal spike trains, continued improve-
ments in the quality and functional utility of prosthetic vision
may be realized in the future.
6.3.3. Outcome measures
Once visuotopic mapping of phosphenes is complete, the
ability of the implant to provide the recipient with function-
ally useful visual perception must be tested.
As discussed in detail by Dagnelie (2008) and others (Chen
et al., 2009a), tools for prosthetic vision assessment should
permit the quantiﬁcation of implant performance across a
variety of domains, ranging from simple light, direction and
motion perception, to improvements in the ability of recipi-
ents to complete routine daily tasks such as obstacle avoid-
ance, self-grooming and food preparation. As recently
highlighted by Rizzo and Ayton (2014), a key concern in this
context is the lack of standard tests and scoring systems,
limiting the ability of researchers to compare results.
Recipients of the early Brindley (Brindley and Rushton,
1974) and Dobelle (Dobelle et al., 1976) cortical implants were
assessed in terms of their ability to read Braille characters
and conventional letters. Later iterations of the Dobelle
system were tested using more conventional tools such as
Landolt rings and Snellen charts, with which the visual acuity
of one implant recipient was estimated at 20/1200, achieved
via head scanning (Dobelle, 2000). Since Dobelle's last pub-
lication in the scientiﬁc literature, there have been no further
reports of visual acuity or functional performance testing in
cortical visual prosthesis recipients.
Conversely, the development and subsequent implanta-
tion in humans of retinal devices has enabled the application
of newer testing paradigms to patients experiencing real-
world prosthetic vision. For example, recipients of the Alpha
IMS (Stingl et al., 2013) and Argus II (da Cruz et al., 2013; Dorn
et al., 2013) retinal implants have been assessed using a
variety of visual acuity tests including the Basic Assessment
of Light and Motion (BALM) (Bach et al., 2010; Wilke et al.,
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tests, Landolt rings, individual letters and words of 2–4 letters
in length or motion of high-contrast rectangles on computer
screens. Stingl et al. (2013) also reported on the recipients'
experiences with activities of daily living (ADL), such as
recognition and location of objects, and navigating the
environment, with one recipient achieving poor ADL results,
despite satisfactory tests of visual acuity. Notably, the
authors report that recipients for whom positive results were
obtained on the ADL tasks described the ADL improvements
as the most rewarding beneﬁt provided by the implant (Stingl
et al., 2013).
Direct translation of the applicability of these vision
scoring techniques to cortical implant recipients may be
complicated by differences in the nature of cortical vs. retinal
prosthetic vision. While such considerations remain specu-
lative in the context of large-scale patterned ICMS, it is
known that the cortical magniﬁcation factor theoretically
allows for signiﬁcantly larger numbers of small phosphenes
in the central visual ﬁeld, with expected increases in visual
acuity (Dagnelie, 2008). Moreover, we expect phosphenes to
be largely limited to this area unless electrode implantation
extends to the medial primary and secondary visual cortices
(Srivastava et al., 2007). Techniques such as head scanning
will likely be necessary to optimize the functionality of future
cortical prosthesis implants, and will therefore need to be
incorporated into prosthesis assessment procedures (Cha
et al., 1992b, 1992c; Chen et al., 2006).
The types of vision assessment tasks most appropriate for
cortical prosthetic vision may also depend on the method of
image processing employed in the system design. For exam-
ple, system designs utilizing the aforementioned intensity-
based image processing techniques vs. those employing a
machine vision type of symbolic image representation may
dictate a radically different approach to prosthetic vision
assessment.
In summary, functional measures will form a central
component of any post-implant assessment regimen, how-
ever regulatory authorities focus more on tests of visual
acuity as measures of functional success (Dagnelie, 2008).
This may only change with a concerted effort by visual
prosthesis researchers to develop a framework for standard
testing paradigms appropriate to prosthetic vision (Rizzo and
Ayton, 2014).
6.4. Stability of the electrode–brain interface
One of the key obstacles to developing a cortical visual
prosthesis is the observed deterioration of the interface
between the electrode and brain tissue. Studies of implanted
electrodes for both neural recording and cortical stimulation
show highly variable patterns of stability over time (Polikov
et al., 2005). In some cases electrodes may simply fail to
function after implantation (Torab et al., 2011), or failure
manifests gradually over a period of months to years as a loss
of recording capability (Hochberg et al., 2012; Rousche and
Normann, 1998) or increases in stimulation threshold cur-
rents to excessive levels (Davis et al., 2012). The implications
of this loss of electrode performance may depend on the
application. For example, in the case of a motorneuroprosthesis, loss of signals from some electrodes may
not grossly impair system functioning as demonstrated by
the successful operation of a robotic arm and hand by a
tetraplegic volunteer with a neural recording array implanted
5 years prior (Hochberg et al., 2012). As described previously, a
loss of the ability to elicit phosphenes from some electrodes
may require advanced image processing algorithms to max-
imize the utility of remaining phosphenes. However, there
will undoubtedly be a threshold below which implant func-
tionality deteriorates to the point that neither software nor
behavioral changes can compensate. Thus regardless of the
application, long-term efﬁcacy of a neural prosthesis is
predicated largely on the electrode/tissue interface remaining
viable.
There are a variety of proposed mechanisms underlying
the gradual loss of electrode functionality, which largely
center on the reactive tissue response to the insertion,
continued presence of, and adverse effects of electrical
stimulation with intracortical electrodes (Polikov et al., 2005).
6.4.1. Electrode encapsulation, chronic inﬂammation and
neurodegeneration
The cortical tissue response to passive (i.e. unstimulated)
electrode insertion and chronic presence has been examined
in a variety of experimental conditions involving both ani-
mals and humans. Immunohistochemical studies at varying
time points after implantation reveal acute and chronic
astrocytic and microglial encapsulation of electrodes (Biran
et al., 2005; Edell et al., 1992; Kozai et al., 2012; Szarowski
et al., 2003), and chronic inﬂammation with localized neuro-
degeneration (Azemi et al., 2011; Biran et al., 2005; McConnell
et al., 2009) that combine to increase the separation of viable
neurons from the electrode surface. Importantly, this
response may be highly variable, even within an individual
electrode array. The factors mediating the extent of tissue
response are still being characterized, however a number of
mechanisms have been examined or proposed. These include
the extent of vascular injury occurring during electrode
insertion (Bjornsson et al., 2006; House et al., 2006; Kozai
et al., 2010), the amount of strain experienced by cortical
tissue during penetration of the pia mater (Bjornsson et al.,
2006; Rennaker et al., 2005; Rousche and Normann, 1992), the
geometry of electrodes (Seymour and Kipke, 2007; Skousen
et al., 2011) and micromotion-induced injury due to a stiff-
ness mismatch between electrodes and cortical tissue, or by
electrode tethering (Biran et al., 2007; Freire et al., 2011; Lind
et al., 2010).
A variety of approaches are being explored to minimize
the extent of glial encapsulation and chronic neuroinﬂamma-
tion. A reduction in vascular injury may be achieved by
careful placement of electrodes deliberately avoiding surface
vessels (Kozai et al., 2010), implanting ﬂexible electrodes that
can deﬂect off vascular structures (Bjornsson et al., 2006), or
by customizing electrode arrays to account for the distribu-
tion of vessels at the cortical surface of the recipient
(Ortmann and Baziyan, 2007).
Some disagreement exists about the optimal combination
of insertion speed and electrode tip sharpness required to
penetrate the pia with minimal tissue compression; Nicolelis
et al. (2003) advocate for the ultra-slow insertion (100 mm/min)
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and Normann (1992) suggest that to minimize cortical
compression and achieve uniform insertion depth of the
100-electrode Utah Electrode Array (UEA), very high speed
(48.3 m/s) insertions of electrodes with sharp tips are
required in cats. Notably, the same group suggest that even
higher speeds may be required for implantation of arrays into
the larger human brain, with its differing biomechanical
properties and thicker pial layer (House et al., 2006). Weak-
ening of the pia by pretreating with collagenase prior to
electrode insertion has also been shown to reduce insertion
forces (Paralikar and Clement, 2008).
Reductions in glial encapsulation and neuronal loss may
also be achieved by using electrodes with very low surface
areas (Skousen et al., 2011), or greater ﬂexibility (Harris et al.,
2011).
Alternative approaches to controlling the tissue response
that have been suggested or are being explored include
biologically-active electrode coatings (Azemi et al., 2010,
2011; He et al., 2007; Zhong and Bellamkonda, 2007), immu-
nomodulation via drug delivery through microﬂuidic chan-
nels in the electrodes (Abidian et al., 2009), or systemic
administration of immunomodulatory agents (Freire et al.,
2011; Shain et al., 2003).
6.4.2. Adverse effects of stimulation
Complicating the chronic tissue response to the presence of
intracortical electrodes is the inﬂuence of chronic electrical
stimulation itself. Histologically conﬁrmed neuronal degen-
eration can be seen following electrical stimulation of cortex,
which is unrelated to the presence of electrodes (McCreery
et al., 1988). This damage manifests acutely as edematous,
hyperchromic and shrunken neurons, progressing to vacuo-
lation, degeneration and cell death (McCreery et al., 1988).
Of the factors mediating the degree of tissue damage,
irreversible electrochemical (Faradic) reactions occurring at
the electrode/tissue interface are a well-known problem.
These reactions may lead to electrode degradation or dela-
mination of oxide layers, in addition to hydrolysis causing
gas bubble formation and injurious pH shifts within sur-
rounding tissue (Cogan, 2008). The risk of irreversible electro-
chemical reactions is lowered by using electrodes with high
charge injection capacity (CIC), enabling neuronal stimulation
while allowing electrode voltages to remain within safe levels
(Negi et al., 2010). Well-studied materials with high CIC
include iridium oxide ﬁlms (Negi et al., 2010), with newer
options offering even higher CIC including electrodes coated
with poly(3,4-ethylenedioxythiophene) (PEDOT) (Wilks et al.,
2009), roughened silicon coated with platinum (Negi et al.,
2012) or silicon electrodes containing embedded carbon
nanotubes (Musa et al., 2012).
Aside from electrochemical reactions at the probe/tissue
interface, neuronal stimulation at levels required for elicita-
tion of behavioral responses can be injurious to tissue. The
likelihood of damage is related to the amount of electric
charge delivered per stimulus pulse (charge per phase), acting
in combination with the surface area of the electrode stimu-
lating surface, which determines the density of charge
(McCreery et al., 2010b, 1990). Therefore, the density of charge
is also seen to be a mediating factor in determining thelikelihood of tissue damage. In a study of the effects of
chronic (7 h per day) stimulation over periods of 30 days,
McCreery et al. (2010b) noted that the duty cycle, which refers
to the ratio of time spent in the stimulus-on vs. stimulus-off
state, can also inﬂuence the degree of tissue damage. The
authors pointedly commented on the requirement for further
study to determine whether the degree of neuronal damage
due to the 50% duty cycle stimulus regimen represented a
steady-state condition.
The likelihood of damage at higher levels of charge per
pulse may be reduced by using electrodes with higher geo-
metric surface areas (GSA) (McCreery et al., 2010b), or by
increasing the real surface area (RSA) via surface roughening
while maintaining the GSA (Negi et al., 2012). While increas-
ing the GSA may be at the expense of stimulating larger
populations of cortical neurons and therefore reducing the
potential resolution of a visual prosthesis, it may result in
improved electrode stability and performance over time
(Davis et al., 2012). An electrode design with a large GSA
was tested recently by Wang et al. (2013), in which the
stimulating area was an annulus of exposed electrode distal
to the tip. These electrodes were chronically implanted into
rat motor cortex, and demonstrated stable current thresholds
for evoking whisker movement over a period of 100 days, at
charge levels beyond those previously deﬁned for inducing
neuronal injury (Wang et al., 2013). Notably, the charge was
delivered only intermittently over a period of three months,
so longer-term trials are required to establish the validity of
these ﬁndings in the chronic setting.
The precise biological mechanisms underpinning neuro-
nal degeneration due to electrical stimulation are relatively
poorly understood. McCreery et al. (1988) observed that
neuronal loss was independent of electrode type (i.e. faradic
vs. capacitative), suggesting that the phenomenon can occur
in the absence of electrochemical reactions occurring at the
electrode/tissue interface. The authors hypothesized that the
damage may be mediated by stimulation-induced neuronal
hyperactivity, notably observing the relative preservation of
glial cells in the presence of neuronal degeneration (McCreery
et al., 1988). Support for this theory was provided by admin-
istering an N-methyl D-aspartate (NMDA) receptor antagonist
during stimulation of cats with surface electrodes, which
reduced the degree of neuronal damage compared to
untreated animals and suggested a glutamate-mediated
mechanism (Agnew et al., 1993).
A key question surrounding stimulation-induced neuro-
degeneration and chronic tissue responses is whether the
degree of damage is sufﬁcient to cause device failure. The
functional relevance of neuronal loss may depend on the
relative excitabilities of and proximity to stimulating electro-
des of neurons mediating phosphene induction (McCreery
et al., 2010a; Tehovnik and Slocum, 2013). Examining the
ability of an electrode array to elicit phosphenes 2 years after
implantation into the visual cortex of a macaque, Davis et al.
(2012) reported that 77/96 individual electrodes failed to
consistently elicit behavioral responses at currents up to
200 mA. The authors then stimulated with groups of four
and nine contiguous electrodes, ﬁnding that 24/36 four-
electrode groups produced functional responses at approxi-
mately 200 mA per electrode, and all 8 nine-electrode groups
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et al., 2012).
Taken together, these studies suggest that while
stimulation-induced efﬁcacy of individual electrodes may be
preserved over a period of months, the chronic tissue
response to penetrating electrodes may require reconﬁgura-
tion of stimulus parameters to maintain device efﬁcacy over
time. An obvious drawback to increasing the number of
concurrently stimulated electrodes in particular is the poten-
tial for a gradual reduction in the resolution of the resulting
phosphene map. Davis et al. (2012) reported that the precision
of saccades to percepts elicited with multiple-electrode
groups was less than those to photic stimuli, suggesting that
the percepts elicited with larger groups of electrodes were
larger. However, the same authors point out that a previous
study (Bradley et al., 2005) also showed inferior precision of
saccades to percepts elicited by stimulation with single
electrodes compared to photic stimuli. In that study Bradley
et al. (2005) suggested that this loss of precision may be the
result of differences in the way electrically-evoked percepts
are committed to short-term memory, a question that
remains unresolved.
6.5. Seizure risks
Additional considerations in the context of chronic stimula-
tion include the risk of stimulation-induced alterations in
neuronal excitability. From a safety perspective, the risks of
seizure induction cannot be understated. Parker et al. (2011)
noted that simultaneous stimulation of 72 cortical electrodes
at 25 mA induced a tonic seizure in cats. Given this observa-
tion of a seizure in an animal model, and previous reports of
seizures in human recipients of cortical surface implants
(Naumann, 2012; Pudenz, 1993), it is pertinent to discuss the
risk of cortical kindling.
Cortical kindling describes the evolution of electrical
stimulus response from the expected transient increase in
neuronal ﬁring, to the development of after discharges and
eventually seizures with no increase in stimulus current
(Goddard et al., 1969). This phenomenon is readily observed
in the amygdale (Goddard et al., 1969), and the susceptibility
of visual cortex to kindling is of direct relevance to the long-
term safety of a cortical visual prosthesis. Previous studies
have demonstrated the development of neuronal after-
discharges or generalized seizure progression (kindling) in
the visual cortex of cats (Pollen, 1977; Wada et al., 1989),
rabbits (Jibiki et al., 1988) and primates (Goddard et al., 1969;
Poggio et al., 1956). Comparing the susceptibilities of the
amygdala and visual cortex to kindling in cats, Wada et al.
(1989) noted that visual cortex required much higher currents
to elicit afterdischarges. Moreover, the same authors noted
that once progression to a seizure response had been
achieved through repeated stimulation, there was frequently
regression to a non-convulsive response by visual cortex,
whereas the amygdala retained its kindled state (Wada et al.,
1989). Wada's observations in cats are consistent with the
earlier macaque studies of Poggio et al. (1956), in which
repeated stimulation of occipital cortex produced less fre-
quent and shorter visual cortical afterdischarges, and with
less subcortical progression than other parts of the brain.Bartlett et al. (1977) also noted that even with high current
(5.0 mA) stimulus of macaque visual cortex, afterdischarges
did not propagate beyond 6 mm from the site of stimulation.
The inﬂuence of long-term blindness on the susceptibility
of visual cortex to the development of seizures and/or
kindling following long-term electrical stimulation is poorly
understood. Examining the susceptibility of visual cortex to
kindling in immature and adult cats, Moneta and Singer
(1986) noted that the developing visual cortex had a higher
afterdischarge threshold and was more resistant to the
kindling effect. In discussing potential mechanisms for the
observed reduction in cortical excitability in kittens, the
authors postulated that visual input may antagonize any
kindling response (Moneta and Singer, 1986). Importantly, in
the blind human subject, there would be no such visual input,
potentially increasing the risk of a kindling response. Clearly
this is an area requiring further research.
Seizure risk mitigation may be achieved with anticonvul-
sant medications such as phenytoin, which is known to
suppress both neuronal afterdischarges in cats by raising
the threshold current for their elicitation (Pollen, 1977; Wada
et al., 1990), in addition to suppressing kindled seizures
(Wada et al., 1990). Alternatives include sodium valproate,
which has been shown to elevate afterdischarge threshold
and prevent convulsions in a rat model of amygdala kindling
(Salt et al., 1980). There is little data on the prevention of
kindled occipital seizures in humans, however occipital
epilepsies generally respond equally well to a wide range of
antiepileptics, although if a photosensitive component is
present, then sodium valproate may be more effective
(Taylor et al., 2003). Whether or not photosensitive epilepsy
is a more appropriate model for kindled visual cortex seizures
is a subject that requires further investigation.
One possible seizure risk mitigation strategy proposed by
Parker et al. (2011) was the interleaving of stimuli, maximiz-
ing the distance between any two individual, or groups of
stimulated electrodes. This may have the added beneﬁt of
reducing another undesired side-effect of chronic stimula-
tion, being the depression of neuronal excitability that is seen
following 7 h of constant stimulation and may persist for
several days (McCreery et al., 1997, 2002). Therefore by
avoiding parallel stimulation of electrodes with overlapping
current spread, reduction in the multiple deleterious effects
of prolonged, chronic and constant stimulation may be
avoided.
6.6. Electrode array design
Several considerations in the design of penetrating cortical
electrode arrays for a visual prosthesis have been discussed
throughout previous sections. Several additional major
concerns are worthy of discussion, and these are brieﬂy
covered here.
6.6.1. Electrode penetration depth
Multiple studies report a clear depth–threshold relationship
for phosphenes elicited by electrical stimulation with pene-
trating microelectrodes (Bak et al., 1990; Bartlett and Doty,
1980; Bartlett et al., 2005; DeYoe et al., 2005; Koivuniemi et al.,
2011; Tehovnik et al., 2003). These studies consistently show
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the surface, to the extent that the ratio of maximum to
minimum thresholds may be as high as 100:1 (Bak et al.,
1990). Thus, penetration of electrodes to a depth at which the
stimulus threshold for phosphene perception is minimized
will be an important consideration in not only preventing
current spread overlap and therefore maintaining the dis-
criminability of phosphenes, but also for reducing total power
consumption by the device. This latter point may be of
critical importance in future implant designs employing
many hundreds of electrodes.
The precise cortical depth at which phosphene detection
thresholds reach a minimum remains a point of some
conjecture. The early macaque studies of Bartlett and Doty
(1980) concluded that the lowest thresholds were found in
layers V/VI of macaque visual cortex, corresponding to a
depth of 1.5 mm. More recently, DeYoe et al. (2005) reported
that layers III–IVb of macaque visual cortex consistently
demonstrated the lowest thresholds. Conversely, Tehovnik
et al. (2003) reported the lowest thresholds from the border of
layers V/VI (at a depth of 1.75 mm), later contending that the
signiﬁcant variation in threshold beyond layer III reported by
DeYoe et al. (2005) may have been due to electrode damage
(Tehovnik and Slocum, 2013). Bradley et al. (2005) implanted
electrodes varying in length between 0.7 and 1.5 mm into the
visual cortex of a macaque, however they made no speciﬁc
comment on differences in stimulus current threshold at
these varying depths. Torab et al. (2011) implanted 2 arrays of
100 electrodes each into the visual cortex of a macaque,
noting that behavioral responses could only be elicited from
5/37 stimulated electrodes in one array, and 3/45 electrodes in
the other. Notably, the electrodes were 1 mm in length, and
the authors commented that the plane within which the
electrode tips were situated was likely not parallel with that
of the cortical laminae, resulting in variable penetration
depth across the array. This also correlated with differences
in the level of background neuronal activity, with those
electrodes recording the highest levels of activity tending to
be those that produced behavioral responses (Torab et al.,
2011).
The available data on visual cortex intracortical micro-
stimulation in humans addresses the question to a limited
extent only. Bak et al. (1990) recorded threshold minima at
depths of 2–3 mm, 4 mm and 4.5 mm in three sighted volun-
teers undergoing occipital craniotomy for excision of epileptic
foci. In the patient with the lowest detection thresholds, they
plotted the threshold stimulus current vs. electrode depth,
showing the lowest thresholds (20 mA) at a depth of approxi-
mately 2.25 mm. In their subsequent study on a blind volun-
teer, the same group reported thresholds varying from 1.9 mA
to 77 mA using ﬁxed-length electrodes implanted to a depth of
2 mm (Schmidt et al., 1996).
As noted by Torab et al. (2011), the undulating nature of
the cerebral cortex renders it difﬁcult to ensure consistent
penetration depth of all electrodes with an array based on a
rigid substrate. Moreover, the ability of electrodes to elicit
behavioral responses at current levels not damaging to the
electrodes or tissue may be predicated partly on the location
of electrode stimulating sites within laminae containing the
most excitable neuronal elements. Spatial differences inthreshold current (DeYoe et al., 2005) or depth of lowest
threshold (Bak et al., 1990) and natural variations in the
thickness of V1 (Fischl and Dale, 2000) may therefore combine
to present a signiﬁcant challenge for ensuring implantation
of electrodes to the optimal depth in visual cortex. Possible
solutions to these problems include the implantation of
arrays with electrode shanks of varying length as previously
described (Bradley et al., 2005), which may require an
increase in the density of electrodes, e.g. (Wark et al., 2013)
to preserve the resolution of the phosphene map. Another
possible solution could be the incorporation of multiple
stimulating sites onto individual electrode shanks
(Changhyun and Wise, 1996) or microdrives that allow inde-
pendent adjustment of electrode penetration depth (Gray
et al., 2007; Yamamoto and Wilson, 2008; Yang et al., 2010).
For the latter, further reductions in the size of the positioning
hardware will be required before integration into high elec-
trode count arrays is a realistic possibility.
Reductions in the size of electrode arrays may also offer
some beneﬁts; for example, the Illinois group and EIC Labora-
tories recently described a 22 mm, 16-electrode array (Kane
et al., 2013) that may permit improved consistency of elec-
trode tip depth relative to the curved cortical surface when
implanted over a wide area. One potential disadvantage to
this approach is the larger number of arrays to be implanted,
and its potential implications for the length of the surgical
procedure. For example, implanting 650 electrodes in groups
of 16 would require approximately 41 arrays (Srivastava et al.,
2007), while implanting 500 electrodes in groups of 43 would
require only 11 (Lowery, 2013).
6.6.2. Accessing the buried calcarine cortex
Further to the question of variable electrode penetration
depth, there remains the problem of the surgical inaccessi-
bility of the signiﬁcant region of V1 buried within the
calcarine ﬁssure, which serves a large area of the lateral
visual ﬁelds. Brindley and Lewin (1968) illustrated the dis-
tribution of phosphenes derived from stimulation of the
accessible areas of the medial calcarine cortex and occipital
pole, wherein the expected absence of phosphenes in the
nasal and temporal hemiﬁelds is evident. However, as dis-
cussed in Section 6.3.1, stimulation of parastriate visual
cortex can also elicit phosphenes, and these may in fact
map to areas of the visual ﬁeld also subserved by primary
visual cortex buried inside the calcarine ﬁssure.
Splitting the Calcarine ﬁssure would necessarily result in a
degree of vascular trauma over and above that resulting from
the electrode insertion itself, increasing the risk of bleeding
and disruption to local cortical blood ﬂow. Even if the cortex
buried within the ﬁssure was surgically exposed, implanting
an array of penetrating electrodes would be a complex
procedure. Another approach may be to slide a ribbon of
surface electrodes into the ﬁssure, although this would be
done at the expense of stimulation power requirements,
seizure risk and phosphene size. A patent for such a device
has been granted (Lauritzen et al., 2014), however no reports
of stimulation of buried calcarine cortex using ribbon electro-
des could be retrieved at the time of writing.
Another alternative may be to implant an array of pene-
trating electrodes on the medial surface of V1, wherein the
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ﬁssure. If the electrodes were fabricated with multiple stimu-
lating sites (Changhyun and Wise, 1996), stimulation of both
superﬁcial and deeper cortical layers could be achieved from
single electrode shanks. A major challenge in this approach
would be the insertion of electrodes to the correct depth
without electrode bending or breakage, for which the use of a
stiff, removable carrier or “shuttle” may be one solution
(Kozai and Kipke, 2009).
Given the increased surgical risk associated with splitting
the calcarine ﬁssure and the potential for stimulation of
secondary visual cortices to expand the phosphene map,
there may be minimal requirement for stimulating the buried
calcarine cortex. This uncertainty will only be addressed by
future human studies.6.6.3. Wireless power and data transmission
Unlike earlier designs (Dobelle, 2000), current-generation
cortical (and retinal) visual prostheses are being developed
to operate wirelessly. Given the large numbers of electrodes
likely to be implanted, it is a major challenge for a wireless
interface to transmit data signals and provide enough power
to the stimulating hardware.
A common method for wirelessly operating implantable
medical devices (IMDs) is by using electromagnetic induction
(Rasouli and Phee, 2010), although novel alternatives include
using ultrasound (Sanni et al., 2012) or light (Abdo and Sahin,
2011) to transfer power or data through tissue. Using the
induction method, an alternating electric current in a wire coil
(the transmitter) induces a magnetic ﬁeld which causes current
to ﬂow in a separate coil (the receiver) that has no physical
connection with the ﬁrst. The current in the receiving coil can
then be transformed into a power source for the implanted
hardware or data signals can be extracted. Several limiting
factors in this approach complicate the design of wireless
stimulating implants of any kind, neural prostheses included.
The ﬁrst is that the most efﬁcient transfer of electromagnetic
energy between the primary and secondary coils occurs when
the coils directly appose each other; physical separation and
misalignment therefore impose an efﬁciency penalty due to the
“uncoupling” of the transmitting and receiving coils (Rasouli
and Phee, 2010). In particular, rapid reductions in power
transfer efﬁciency are seen with relative angles 4201 between
the transmitting and receiving coils (Ng et al., 2011). This is
particularly problematic for retinal implants, in which eye
movement may require the use of additional coil pairs to
ensure consistent coupling (Ng et al., 2011).Table 2 – Speciﬁcations of selected wireless inductive links for
Kiani and Ghovanloo (2014)
Stated purpose Nonspeciﬁc neural
prosthesis
Data direction (up/down/both) Both
Separate data/power coils Yes
Data/power signal frequency
(MHz)
50/13.56
Max. data rate (Mbps) 13.56
Max. # of stimulating channels NAIn a cortical prosthesis the implanted electrode arrays may
be self-contained, including inductive coils for power and
data transmit/receive (Lowery, 2013; Rush et al., 2011), or the
power/data transfer electronics and coil may be separate
from the arrays themselves (Coulombe et al., 2007). An
advantage of the self-contained array approach is the lack
of any requirement for tethering, which may reduce damage
to the cortex from relative motion of the brain and arrays in
the long term (see Section 6.3.1). However, a disadvantage of
the self-contained coils is the variation in coupling between
the individual implanted array coils and the external coil. For
example, arrays implanted on the medial surface of the
occipital pole may be at a greater angle to the transmitting
coil than those on the more lateral surface. Furthermore, if
arrays are implanted more anteriorly onto medial calcarine
cortex, these would be more distant from, and orthogonal to
the external coil than the more superﬁcial arrays, resulting in
poor or zero coupling and energy transfer. Aside from
tethering medial arrays to a more superﬁcially-mounted coil,
alternatives may include the aforementioned optical or ultra-
sonic approaches to power and/or data transfer.
Another consideration in the use of wireless power and
data transfer derives from the absorption of electromagnetic
energy by tissue, which increases exponentially with fre-
quency (Al-Kalbani et al., 2012); the need to transfer sufﬁcient
power while maintaining high data transfer rates therefore
introduces competing constraints that complicate the design
process. Moreover, the separate wire coils used for data and
power transfer can interfere with each other, introducing
complexity to the design of receiving hardware (Kiani and
Ghovanloo, 2014; Rush et al., 2011).
Nonetheless, several inductive link designs have been
described or developed in recent years that may support the
power and data transfer requirements of a high electrode
count cortical visual prosthesis. The general speciﬁcations of
these systems are summarized in Table 2; these have been
included either because they were, as stated in each report,
speciﬁcally designed for use in a high electrode count cortical
visual prosthesis, retinal prosthesis, or both. A key require-
ment for inclusion was that the performance of the inductive
link must have been evaluated over a distance of Z10 mm,
which we consider as the likely minimum distance between
the external coil and the cortical electrode arrays.6.6.4. Brain temperature
Energy dissipated as heat by the implant remains a problem of
concern. A high electrode count, continuous stimulation andpower and/or data transfer to a visual prosthesis.
Lo et al. (2013) Monge et al. (2013) Coulombe et al. (2007)
Retinal
prosthesis
Retinal prosthesis Cortical prosthesis
Down Down Both
Yes Yes No
20/2 160/10 13.56/1.5
2 20 1.5
1024 512 992
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 3 67the possibility of increasing current requirements if the elec-
trode/tissue interface becomes impaired over time, all con-
tribute to the potential for high power requirements and
therefore greater temperature increases. Studies of focal and
whole-brain heating over short periods (30 min), have shown
that temperature rises up to 43 1C can be tolerated without
damage (Coffey et al., 2014; Haveman et al., 2005). In the
context of a cortical visual prosthesis, stimulation is likely to
be continuous over a period of hours, therefore the implant
must remain at low temperatures to prevent tissue damage.
There is little data on the damage to neural tissue resulting
from chronic, focal cortical hyperthermia, although some
information is available from the literature on heating of
tissue due to ultrasound exposure. O’Brien et al. (2008)
reviewed the literature on thermal effects of ultrasound,
including several studies on cat and rabbit brain. From these
studies, a conservative temperature–time exposure boundary
was produced, which suggests that increases in temperature
of 2 1C above 37 can be safely tolerated for lengthy periods (up
to 50 h). An important consideration in this context is the
normal human brain temperature, which was found in a
recent magnetic resonance spectroscopy study to vary region-
ally between 34.9 1C and 37.1 1C, and to not differ greatly from
core body temperature (Childs et al., 2007). The authors
commented on some methodological contributions to the
measured variation, however it is also known that a tempera-
ture gradient exists between cortical and subcortical regions,
with cortical temperature typically being lower by up to 1 1C
(Mellergard, 1995). Considering the previously-mentioned 39 1C
limit (O’Brien et al., 2008), it would seem that the window of
thermal safety may vary from one individual to another.
Moreover, the stimulation itself may contribute to tempera-
ture changes via alterations in oxidative metabolism and
cerebral blood ﬂow (Yablonskiy et al., 2000), while increasedFig. 3 – A simpliﬁed representation of the Monash Vision Group
include a spectacles-mounted camera (a), which passes digitized
the image data prior to wireless transmission. The pocket proces
a laptop computer (c). The processed image data is transmitted
communication with the wirelessly-powered, tiled electrode arra
to layer IV of visual cortex, indicated by the light shaded area incerebral blood ﬂow will itself result in greater heat dissipation
(Kim et al., 2007); therefore the accurate estimation of the
likely temperature increase due to dense, patterned visual
cortex stimulation is a complex task. Kim et al. (2007) esti-
mated temperature increases of 0.029 1C per milliwatt of
power dissipated by an electrode array with 100 electrodes,
however the power dissipation was based on the system
operating as a neural recording device only; we expect that a
stimulating array would not only inﬂuence local temperatures
via increasing metabolism, but it would also consume more
power and result in greater heat accumulation. While further
study in this area is clearly required to determine the safe
limits of operation for a multi-array cortical visual prosthesis,
a possible solution to the problem may be incorporating
temperature sensors into the implants, which was recently
demonstrated in a subretinal visual prosthesis (Liu et al., 2014).6.6.5. Hermeticity
Preventing the ingress of bodily ﬂuids will be essential
for maintaining the functionality and longevity of a visual
prosthesis, and will require the tight sealing of all joins
between materials comprising the electrode arrays. A
detailed treatment of the engineering, materials design and
manufacturing issues involved is beyond the scope of this
review, however it is noteworthy that in-vitro testing of an
encapsulated Utah slant array over a period of 9 months
revealed no deterioration of device performance that would
indicate a failure of hermetic sealing (Sharma et al., 2011).
Moreover, with reports of neural recording arrays functioning
in-vivo in humans (Hochberg et al., 2012) over periods of 5
years, manufacturing techniques have clearly developed to
the point that maintenance of array hermeticity over the
lifespan of the visual prosthesis will be achievable.cortical visual prosthesis system. Components of the system
visual imagery to a pocket processor (b) that itself processes
sor can be monitored and reprogrammed via a cabled link to
wirelessly via an antenna (d), which allows bidirectional
ys implanted into visual cortex (e). The electrodes penetrate
the exploded view of (e).
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 3687. Conclusions
The rapidly growing ﬁeld of medical bionics offers the potential
of partially restoring visual function in individuals with severe
visual impairment. We have summarized the clinical impera-
tive for a cortical visual prosthesis, the general design principles
and some of the major hurdles facing research groups who are
currently developing this technology. Our research group, based
at Monash University in Melbourne, Australia, is developing a
wireless prosthetic vision system based on cortical microsti-
mulation (Fig. 3) (Lowery, 2013). The project is nearing technical
completion, and preclinical, biocompatibility and functional
testing of an implantable device is currently underway in
normally-sighted sheep and macaques. We anticipate that the
results of this study, and others reporting similar progress in
the ﬁeld, should underpin the imminent trial of a new genera-
tion of cortical visual prostheses in humans.Acknowledgments
The authors would like to thank Dr. Jeanette Pritchard for her
assistance with proofreading the manuscript, and Mr. Gavin
Hawkins for his assistance with the preparation of Fig. 3.
This project is funded through the Australian Research
Council's Research in Bionic Vision Science and Technology
Initiative (SRI 1000006).
r e f e r e n c e s
Abdo, A., Sahin, M., 2011. Feasibility of neural stimulation with
floating-light-activated microelectrical stimulators. IEEE
Trans. Biomed. Circuits Syst. 2011, 1.
Abidian, M.R., et al., 2009. Interfacing conducting polymer
nanotubes with the central nervous system: chronic neural
recording using poly(3,4-ethylenedioxythiophene) nanotubes.
Adv. Mater. 21, 3764–3770.
Agnew, W.F., et al., 1993. MK-801 protects against neuronal injury
induced by electrical stimulation. Neuroscience 52, 45–53.
Al-Kalbani, A.I., Yuce, M.R., Redoute, J.M., 2012. Safe SAR levels in
inductively powered brain implanted visual prostheses. In:
Proceedings of 2012 International Symposium on
Electromagnetic Compatibility (EMC EUROPE), pp. 1–6.
Ambati, J., Atkinson, J.P., Gelfand, B.D., 2013. Immunology of age-
related macular degeneration. Nat. Rev. Immunol. 13, 438–451.
Andrews, T.J., Halpern, S.D., Purves, D., 1997. Correlated size
variations in human visual cortex, lateral geniculate nucleus,
and optic tract. J. Neurosci. 17, 2859–2868.
Anon., 2005. William H. Dobelle, MD, 1941–2004: ASAIO member,
1970–present. ASAIO J. 51, 1–3.
Anurova, I., et al., 2014. Relationship between cortical thickness
and functional activation in the early blind. Cereb. Cortex.
Arya, R., et al., 2013. Adverse events related to extraoperative
invasive EEG monitoring with subdural grid electrodes: a
systematic review and meta-analysis. Epilepsia 54, 828–839.
Azemi, E., Gobbel, G.T., Cui, X.T., 2010. Seeding neural progenitor
cells on silicon-based neural probes. J. Neurosurg. 113,
673–681.
Azemi, E., Lagenaur, C.F., Cui, X.T., 2011. The surface
immobilization of the neural adhesion molecule L1 on neural
probes and its effect on neuronal density and gliosis at the
probe/tissue interface. Biomaterials 32, 681–692.Bach-y-Rita, P., et al., 1969. Vision substitution by tactile image
projection. Nature 221, 963–964.
Bach-y-Rita, P., et al., 1998. Form perception with a 49-point
electrotactile stimulus array on the tongue: a technical note. J.
Rehabil. Res. Dev. 35, 427–430.
Bach-y-Rita, P., Kercel, S.W., 2003. Sensory substitution and the
human–machine interface. Trends Cogn. Sci. 7, 541–546.
Bach, M., et al., 2010. Basic quantitative assessment of visual
performance in patients with very low vision. Invest.
Ophthalmol. Vis. Sci. 51, 1255–1260.
Bak, M., et al., 1990. Visual sensations produced by intracortical
microstimulation of the human occipital cortex. Med. Biol.
Eng. Comput. 28, 257–259.
Barber, A.C., et al., 2013. Repair of the degenerate retina by
photoreceptor transplantation. Proc. Natl. Acad. Sci. USA 110,
354–359.
Bartlett, J.R., et al., 1977. Deleterious effects of prolonged
electrical excitation of striate cortex in macaques. Brain
Behav. Evol. 14, 46–66.
Bartlett, J.R., Doty, R.W., 1980. An exploration of the ability of
macaques to detect microstimulation of striate cortex. Acta
Neurobiol. Exp. (Wars) 40, 713–727.
Bartlett, J.R., et al., 2005. Psychophysics of electrical stimulation
of striate cortex in macaques. J. Neurophysiol. 94, 3430–3442.
Berg, J.A., et al., 2013. Behavioral demonstration of a
somatosensory neuroprosthesis. IEEE Trans. Neural Syst.
Rehabil. Eng. 21, 500–507.
Bergey, G.K., 2013. Neurostimulation in the treatment of epilepsy.
Exp. Neurol. 244, 87–95.
Biran, R., Martin, D.C., Tresco, P.A., 2005. Neuronal cell loss
accompanies the brain tissue response to chronically implanted
silicon microelectrode arrays. Exp. Neurol. 195, 115–126.
Biran, R., Martin, D.C., Tresco, P.A., 2007. The brain tissue
response to implanted silicon microelectrode arrays is
increased when the device is tethered to the skull. J. Biomed.
Mater. Res. A 82, 169–178.
Bjornsson, C.S., et al., 2006. Effects of insertion conditions on
tissue strain and vascular damage during neuroprosthetic
device insertion. J. Neural Eng. 3, 196–207.
Bourne, R.R., et al., 2013. Causes of vision loss worldwide, 1990-
2010: a systematic analysis. Lancet Glob. Health 1, e339–e349.
Bradley, D.C., et al., 2005. Visuotopic mapping through a
multichannel stimulating implant in primate V1. J.
Neurophysiol. 93, 1659–1670.
Brelen, M.E., et al., 2005. Creating a meaningful visual perception
in blind volunteers by optic nerve stimulation. J. Neural Eng. 2,
S22–S28.
Brelen, M.E., et al., 2006. Intraorbital implantation of a
stimulating electrode for an optic nerve visual prosthesis.
Case report. J. Neurosurg. 104, 593–597.
Brelen, M.E., et al., 2010. Measurement of evoked potentials after
electrical stimulation of the human optic nerve. Invest.
Ophthalmol. Vis. Sci. 51, 5351–5355.
Brindley, G.S., 1965. The number of information channels needed
for efficient reading. J. Physiol. 177, 44 P.
Brindley, G.S., Lewin, W.S., 1968. The sensations produced by
electrical stimulation of the visual cortex. J. Physiol. 196, 479–493.
Brindley, G.S., et al., 1972. The extent of the region of occipital
cortex that when stimulated gives phosphenes fixed in the
visual field. J. Physiol. 225, 57P–58P.
Brindley, G.S., Rushton, D.N., 1974. Implanted Stimulators of the
visual cortex as visual prosthetic devices. Trans. Am. Acad.
Ophthalmol. Otolaryngol. 78, 741–745.
Brindley, G.S., 1982. Effects of electrical stimulation of the visual
cortex. Hum. Neurobiol. 1, 281–283.
Brummer, S.B., Robblee, L.S., Hambrecht, F.T., 1983. Criteria for
selecting electrodes for electrical stimulation: theoretical and
practical considerations. Ann. N. Y. Acad. Sci. 405, 159–171.
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 3 69Brunton, E., Lowery, A.J., Rajan, R., 2012. A comparison of
microelectrodes for a visual cortical prosthesis using finite
element analysis. Front. Neuroeng. 5, 23.
Burton, H., et al., 2002. Adaptive changes in early and late blind: a
fMRI study of Braille reading. J. Neurophysiol. 87, 589–607.
Buschini, E., et al., 2011. Age related macular degeneration and
drusen: neuroinflammation in the retina. Prog. Neurobiol. 95,
14–25.
Button, J., Putnam, T., 1962. Visual responses to cortical
stimulation in the blind. J. Iowa State Med. Soc. 52, 17–21.
Button, J.C., 1958. Electronics brings light to the blind. Radio
Electron. 29, 53–55.
Capelle, C., et al., 1998. A real-time experimental prototype for
enhancement of vision rehabilitation using auditory
substitution. IEEE Trans. Biomed. Eng. 45, 1279–1293.
Carlson, M.L., et al., 2012. Cochlear implantation: current and
future device options. Otolaryngol. Clin. N. Am. 45, 221–248.
Cha, K., Horch, K., Normann, R.A., 1992a. Simulation of a
phosphene-based visual field: visual acuity in a pixelized
vision system. Ann. Biomed. Eng. 20, 439–449.
Cha, K., Horch, K.W., Normann, R.A., 1992b. Mobility performance
with a pixelized vision system. Vis. Res. 32, 1367–1372.
Cha, K., et al., 1992c. Reading speed with a pixelized vision
system. J. Opt. Soc. Am. A Opt. Image Sci. 9, 673–677.
Changhyun, K., Wise, K.D., 1996. A 64-site multishank CMOS low-
profile neural stimulating probe. IEEE J. Solid-State Circuits 31,
1230–1238.
Chapanis, N.P., et al., 1973. Central phosphenes in man: a report
of three cases. Neuropsychologia 11, 1–19.
Chen, S.C., et al., 2006. Psychophysics of prosthetic vision: I.
Visual scanning and visual acuity. Conf. Proc. IEEE Eng. Med.
Biol. Soc. 1, 4400–4403.
Chen, S.C., et al., 2009a. Simulating prosthetic vision: II.
Measuring functional capacity. Vis. Res. 49, 2329–2343.
Chen, S.C., et al., 2009b. Rehabilitation regimes based upon
psychophysical studies of prosthetic vision. J. Neural Eng. 6,
035009.
Childs, C., et al., 2007. Determination of regional brain
temperature using proton magnetic resonance spectroscopy
to assess brain–body temperature differences in healthy
human subjects. Magn. Reson. Med. 57, 59–66.
Chow, A.Y., et al., 2004. The artificial silicon retina microchip for
the treatment of vision loss from retinitis pigmentosa. Arch.
Ophthalmol. 122, 460–469.
Chow, A.Y., Bittner, A.K., Pardue, M.T., 2010. The artificial silicon
retina in retinitis pigmentosa patients (an American
Ophthalmological Association thesis). Trans. Am.
Ophthalmol. Soc. 108, 120–154.
Coffey, R.J., Kalin, R., Olsen, J.M., 2014. Magnetic resonance
imaging conditionally safe neurostimulation leads:
investigation of the maximum safe lead tip temperature.
Neurosurgery 74, 215–224 (discussion 224–225).
Cogan, S.F., 2008. Neural stimulation and recording electrodes.
Annu. Rev. Biomed. Eng. 10, 275–309.
Cohen, L.G., et al., 1999. Period of susceptibility for cross-modal
plasticity in the blind. Ann. Neurol. 45, 451–460.
Collignon, O., et al., 2013. Impact of blindness onset on the
functional organization and the connectivity of the occipital
cortex. Brain 136, 2769–2783.
Collinger, J.L., et al., 2013. High-performance neuroprosthetic
control by an individual with tetraplegia. Lancet 381,
557–564.
Collinger, J.L., et al., 2014. Collaborative approach in the
development of high-performance brain–computer interfaces
for a neuroprosthetic arm: translation from animal models to
human control. Clin. Transl. Sci. 7, 52–59.
Collins, C.C., 1971. Tactile vision synthesis. In: Sterling, T., Bering,
J.E.D., Pollack, S., Vaughan, J.H.G. (Eds.), Visual Prosthesis: TheInterdisciplinary Dialogue. Academic Press, New York, pp.
267–279.
Coulombe, J., Sawan, M., Gervais, J.F., 2007. A highly flexible
system for microstimulation of the visual cortex: design and
implementation. IEEE Trans. Biomed. Circuits Syst. 1, 258–269.
Cudeiro, J., Sillito, A.M., 2006. Looking back: corticothalamic feedback
and early visual processing. Trends Neurosci. 29, 298–306.
da Cruz, L., et al., 2013. The Argus II epiretinal prosthesis system
allows letter and word reading and long-term function in
patients with profound vision loss. Br. J. Ophthalmol. 97,
632–636.
Dagnelie, G., et al., 2003. Phosphene mapping strategies for
cortical visual prosthesis recipients. J. Vis. 3, 222.
Dagnelie, G., 2008. Psychophysical evaluation for visual
prosthesis. Annu. Rev. Biomed. Eng. 10, 339–368.
Daniel, P.M., Whitteridge, D., 1961. The representation of the
visual field on the cerebral cortex in monkeys. J. Physiol. 159,
203–221.
Davis, T.S., et al., 2012. Spatial and temporal characteristics of V1
microstimulation during chronic implantation of a
microelectrode array in a behaving macaque. J. Neural Eng. 9,
065003.
Delbeke, J., Oozeer, M., Veraart, C., 2003. Position, size and
luminosity of phosphenes generated by direct optic nerve
stimulation. Vis. Res. 43, 1091–1102.
Deroy, O., Auvray, M., 2012. Reading the World through the skin
and ears: a new perspective on sensory substitution. Front.
Psychol. 3, 457.
DeYoe, E.A., Lewine, J.D., Doty, R.W., 2005. Laminar variation in
threshold for detection of electrical excitation of striate cortex
by macaques. J. Neurophysiol. 94, 3443–3450.
Dobelle, W.H., 1974. Introduction to sensory prostheses for the blind
and deaf. Trans. Am. Soc. Artif. Intern. Organs 20B, 761–764.
Dobelle, W.H., Mladejovsky, M.G., 1974. Phosphenes produced by
electrical stimulation of human occipital cortex, and their
application to the development of a prosthesis for the blind.
J. Physiol. 243, 553–576.
Dobelle, W.H., et al., 1976. “Braille” reading by a blind volunteer by
visual cortex stimulation. Nature 259, 111–112.
Dobelle, W.H., et al., 1979a. Artificial vision for the blind by
electrical stimulation of the visual cortex. Neurosurgery 5,
521–527.
Dobelle, W.H., et al., 1979b. Mapping the representation of the
visual field by electrical stimulation of human visual cortex.
Am. J. Ophthalmol. 88, 727–735.
Dobelle, W.H., 2000. Artificial vision for the blind by connecting a
television camera to the visual cortex. ASAIO J. 46, 3–9.
Dorn, J.D., et al., 2013. The detection of motion by blind subjects
with the epiretinal 60-electrode (Argus II) retinal prosthesis.
JAMA Ophthalmol. 131, 183–189.
Doty, R.W., 1965. Conditioned reflexes elicited by electrical
stimulation of the brain in macaques. J. Neurophysiol. 28,
623–640.
Duret, F., et al., 2006. Object localization, discrimination, and
grasping with the optic nerve visual prosthesis. Restor.
Neurol. Neurosci. 24, 31–40.
Edell, D.J., et al., 1992. Factors influencing the biocompatibility of
insertable silicon microshafts in cerebral cortex. IEEE Trans.
Biomed. Eng. 39, 635–643.
Espinosa, J.S., Stryker, M.P., 2012. Development and plasticity of
the primary visual cortex. Neuron 75, 230–249.
Fenoy, A.J., Simpson Jr., R.K., 2014. Risks of common
complications in deep brain stimulation surgery:
management and avoidance. J. Neurosurg. 120, 132–139.
Fernandes, R.A., et al., 2012. Artificial vision through neuronal
stimulation. Neurosci. Lett. 519, 122–128.
Fernandez-Robredo, P., et al., 2014. Current treatment limitations
in age-related macular degeneration and future approaches
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 370based on cell therapy and tissue engineering. J. Ophthalmol.
2014, 510285.
Fernandez, E., et al., 2005. Development of a cortical visual
neuroprosthesis for the blind: the relevance of neuroplasticity.
J. Neural Eng. 2, R1–12.
Ferrandez, J.M., et al., 2007. A customizable multi-channel
stimulator for cortical neuroprosthesis. In: 29th Annual
International Conference of the IEEE Engineering in Medicine
and Biology Society, 2007, EMBS 2007, pp. 4707–4710.
Fischl, B., Dale, A.M., 2000. Measuring the thickness of the human
cerebral cortex from magnetic resonance images. Proc. Natl.
Acad. Sci. USA 97, 11050–11055.
Fo¨rster, O., 1929. Beitra¨ge zur Pathophysiologie der Sehbahn und
der Sehsphare. J. Psychol. Neurol. 39, 463–485.
Freeman, D.K., Rizzo 3rd, J.F., Fried, S.I., 2011. Encoding visual
information in retinal ganglion cells with prosthetic
stimulation. J. Neural Eng. 8, 035005.
Freire, M.A., et al., 2011. Comprehensive analysis of tissue
preservation and recording quality from chronic
multielectrode implants. PLoS One 6, e27554.
Genc, E., et al., 2014. Surface area of early visual cortex predicts
individual speed of traveling waves during binocular rivalry.
Cereb. Cortex.
Glickstein, M.F., Whitteridge, D., 1987. Tatsuji Inouye and the
mapping of the visual fields on the human cerebral cortex.
Trends Neurosci. 10, 350–353.
Goddard, G.V., McIntyre, D.C., Leech, C.K., 1969. A permanent
change in brain function resulting from daily electrical
stimulation. Exp. Neurol. 25, 295–330.
Gothe, J., et al., 2002. Changes in visual cortex excitability in blind
subjects as demonstrated by transcranial magnetic
stimulation. Brain 125, 479–490.
Gray, C.M., Goodell, B., Lear, A., 2007. Multichannel
micromanipulator and chamber system for recording
multineuronal activity in alert, non-human primates.
J. Neurophysiol. 98, 527–536.
Guenther, T., Lovell, N.H., Suaning, G.J., 2012. Bionic vision:
system architectures: a review. Expert Rev. Med. Dev. 9,
33–48.
Hanneton, S., Auvray, M., Durette, B., 2010. The Vibe: a versatile
vision-to-audition sensory substitution device. Appl. Bionics
Biomech. 7, 269–276.
Harris, J.P., et al., 2011. Mechanically adaptive intracortical
implants improve the proximity of neuronal cell bodies.
J. Neural Eng. 8, 066011.
Harrop, J.S., et al., 2012. Contributing factors to surgical site
infections. J. Am. Acad. Orthop. Surg. 20, 94–101.
Harvey, B.M., Dumoulin, S.O., 2011. The relationship between
cortical magnification factor and population receptive field
size in human visual cortex: constancies in cortical
architecture. J. Neurosci. 31, 13604–13612.
Hauer, M.C., 2009. (Ph.D. thesis). Intraocular Camera for Retinal
Prostheses: Refractive and Diffractive Lens Systems.
University of Southern California, California.
Haveman, J., et al., 2005. Effects of hyperthermia on the central
nervous system: what was learnt from animal studies? Int. J.
Hyperth. 21, 473–487.
He, W., et al., 2007. A novel anti-inflammatory surface for neural
electrodes. Adv. Mater. 19, 3529–3533.
Hochberg, L.R., et al., 2012. Reach and grasp by people with
tetraplegia using a neurally controlled robotic arm. Nature
485, 372–375.
Holmes, G., Lister, W.T., 1916. Disturbances of vision from
cerebral lesions, with special reference to the cortical
representation of the macula. Brain 39, 34–73.
House, P.A., et al., 2006. Acute microelectrode array implantation
into human neocortex: preliminary technique and histological
considerations. Neurosurg. Focus. 20, E4.Jibiki, I., Kubota, T., Yamaguchi, N., 1988. Visual cortical kindling
in rabbit—consideration of difference between species. Jpn. J.
Psychiatry Neurol. 42, 345–350.
Kalfas, I.H., Little, J.R., 1988. Postoperative hemorrhage:
a survey of 4992 intracranial procedures. Neurosurgery 23,
343–347.
Kane, S., et al., 2013. Electrical performance of penetrating
microelectrodes chronically implanted in cat cortex. IEEE
Trans. Biomed. Eng. 60, 2153–2160.
Kiani, M., Ghovanloo, M., 2014. A 13.56-Mbps pulse delay modulation
based transceiver for simultaneous near-field data and power
transmission. IEEE Trans. Biomed. Circuits Syst. (in press).
Kim, S., et al., 2007. Thermal impact of an active 3-D
microelectrode array implanted in the brain. IEEE Trans.
Neural Syst. Rehabil. Eng. 15, 493–501.
Koivuniemi, A., et al., 2011. Multimodal, longitudinal assessment
of intracortical microstimulation. Prog. Brain Res. 194,
131–144.
Kozai, T.D., Kipke, D.R., 2009. Insertion shuttle with carboxyl
terminated self-assembled monolayer coatings for implanting
flexible polymer neural probes in the brain. J. Neurosci.
Methods 184, 199–205.
Kozai, T.D., et al., 2010. Reduction of neurovascular damage
resulting from microelectrode insertion into the cerebral
cortex using in vivo two-photon mapping. J. Neural Eng. 7,
046011.
Kozai, T.D., et al., 2012. In vivo two-photon microscopy reveals
immediate microglial reaction to implantation of
microelectrode through extension of processes. J. Neural Eng.
9, 066001.
Krause, F., 1924. Die Sehbahn In Chirurgischer Beziehung und die
Faradische Reizung des Sehzentrums. Klin. Wochenschr. 3,
1260–1265.
Krause, F., Schum, H., 1931. Die epileptischen Erkrankungen, ihre
anatomischen und physiologischen Unterlagen sowie ihre
chirurgie. In: Ku¨ttner, H. (Ed.), Neue Deutsche Chirurgie. Enke,
Stuttgart, pp. 482–486.
Kupers, R., et al., 2006. Transcranial magnetic stimulation of the
visual cortex induces somatotopically organized qualia in
blind subjects. Proc. Natl. Acad. Sci. USA 103, 13256–13260.
Kupers, R., et al., 2007. rTMS of the occipital cortex abolishes
Braille reading and repetition priming in blind subjects.
Neurology 68, 691–693.
Lane, F.J., et al., 2012. Responses of potential users to the
intracortical visual prosthesis: final themes from the analysis
of focus group data. Disabil. Rehabil. Assist. Technol. 7,
304–313.
Lauritzen, T., et al., 2014 Cortical Visual Prosthesis. US Patent
US20140222103 A1, Available from: 〈http://www.google.com/
patents/US20140222103〉 (accessed 22.08.14).
Lay, A.H., Das, A.K., 2012. The role of neuromodulation in patients
with neurogenic overactive bladder. Curr. Urol. Rep. 13,
343–347.
Lind, G., et al., 2010. Gelatine-embedded electrodes—a novel
biocompatible vehicle allowing implantation of highly flexible
microelectrodes. J. Neural Eng. 7, 046005.
Liu, C.Y., et al., 2014. In vivo thermal evaluation of a subretinal
prosthesis using an integrated resistance temperature
detector. J. Micro/Nanolithogr. MEMS MOEMS 13 (1), 13006,
http://dx.doi.org/10.1117/1.JMM.13.1.013006.
Lo, Y.K., et al., 2013. A fully-integrated high-compliance voltage
SoC for epi-retinal and neural prostheses. IEEE Trans. Biomed.
Circuits Syst. 7, 761–772.
Loomis, J., 2010. Sensory substitution for orientation and
mobility: What progress are we making?. In: Wiener, W.R.,
Welsh, R.L., Blasch, B.B. (Eds.), Foundations of Orientation and
Mobility (History and Theory), vol. 1. AFB Press, New York, pp.
7–10.
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 3 71Lo¨wenstein, K., Borchardt, M., 1918. Symptomatologie und
elektrische Reizung bei einer Schußverletzung des
Hinterhauptlappens. Deutsch. Z. Nervenheilkd. 58, 264–292.
Lowery, A., 2013. Introducing the Monash Vision Group’s Cortical
Prosthesis. In: IEEE International Conference on Image
Processing. ICIP 2013, IEEE, Melbourne, Australia, pp. 1536–1539.
Lu, Y., et al., 2013. Electrical stimulation with a penetrating optic
nerve electrode array elicits visuotopic cortical responses in
cats. J. Neural Eng. 10, 036022.
Lui, W.L., et al., 2012. Transformative reality: improving bionic
vision with robotic sensing. Conf. Proc. IEEE Eng. Med. Biol.
Soc. 2012, 304–307.
Marg, E., Driessen, G., 1965. Reported visual percepts from
stimulation of the human brain with microelectrodes during
therapeutic surgery. Confin. Neurol. 26, 57–75.
Marg, E., 1991. Magnetostimulation of vision: direct noninvasive
stimulation of the retina and the visual brain. Optom. Vis. Sci.
68, 427–440.
Marin, C., Fernandez, E., 2010. Biocompatibility of intracortical
microelectrodes: current status and future prospects. Front.
Neuroeng. 3, 8.
Maynard, E.M., 2001. Visual prostheses. Annu. Rev. Biomed. Eng.
3, 145–168.
McCarthy, C., Barnes, N., Lieby, P., 2011. Ground surface
segmentation for navigation with a low resolution visual
prosthesis. In: Proceedings of the Annual International
Conference of the IEEE Engineering in Medicine and Biology
Society, EMBS. pp. 4457–4460.
McCarty, C.A., Nanjan, M.B., Taylor, H.R., 2001. Vision impairment
predicts 5 year mortality. Br. J. Ophthalmol. 85, 322–326.
McClements, M.E., MacLaren, R.E., 2013. Gene therapy for retinal
disease. Transl. Res. 161, 241–254.
McConnell, G.C., et al., 2009. Implanted neural electrodes cause
chronic, local inflammation that is correlated with local
neurodegeneration. J. Neural Eng. 6, 056003.
McCreery, D., Han, M., Pikov, V., 2010a. Neuronal activity evoked
in the inferior colliculus of the cat by surface macroelectrodes
and penetrating microelectrodes implanted in the cochlear
nucleus. IEEE Trans. Biomed. Eng. 57, 1765–1773.
McCreery, D., Pikov, V., Troyk, P.R., 2010b. Neuronal loss due to
prolonged controlled-current stimulation with chronically
implanted microelectrodes in the cat cerebral cortex. J. Neural
Eng. 7, 036005.
McCreery, D.B., et al., 1988. Comparison of neural damage
induced by electrical stimulation with faradaic and capacitor
electrodes. Ann. Biomed. Eng. 16, 463–481.
McCreery, D.B., et al., 1990. Charge density and charge per phase
as cofactors in neural injury induced by electrical stimulation.
IEEE Trans. Biomed. Eng. 37, 996–1001.
McCreery, D.B., et al., 1994. Stimulus parameters affecting tissue
injury during microstimulation in the cochlear nucleus of the
cat. Hear Res. 77, 105–115.
McCreery, D.B., et al., 1997. A characterization of the effects on
neuronal excitability due to prolonged microstimulation with
chronically implanted microelectrodes. Trans. Biomed. Eng.
IEEE 44, 931–939.
McCreery, D.B., Agnew, W.F., Bullara, L.A., 2002. The effects of
prolonged intracortical microstimulation on the excitability of
pyramidal tract neurons in the cat. Ann. Biomed. Eng. 30,
107–119.
Meijer, P.B., 1992. An experimental system for auditory image
representations. IEEE Trans. Biomed. Eng. 39, 112–121.
Mellergard, P., 1995. Intracerebral temperature in neurosurgical
patients: intracerebral temperature gradients and
relationships to consciousness level. Surg. Neurol. 43, 91–95.
Merabet, L.B., Theoret, H., Pascual-Leone, A., 2003. Transcranial
magnetic stimulation as an investigative tool in the study of
visual function. Optom. Vis. Sci. 80, 356–368.Merabet, L.B., et al., 2007. ‘Who is the ideal candidate?’: decisions
and issues relating to visual neuroprosthesis development,
patient testing and neuroplasticity. J. Neural Eng. 4,
S130–S135.
Merabet, L.B., et al., 2008. Rapid and reversible recruitment of
early visual cortex for touch. PLoS One 3, e3046.
Merabet, L.B., 2011. Building the bionic eye: an emerging reality
and opportunity. Prog. Brain Res. 192, 3–15.
Mohammadi, H.M., Ghafar-Zadeh, E., Sawan, M., 2012. An
image processing approach for blind mobility facilitated
through visual intracortical stimulation. Artif. Organs 36,
616–628.
Moneta, M.E., Singer, W., 1986. Critical period plasticity of kitten
visual cortex is not associated with enhanced susceptibility to
electrical kindling. Brain Res. 395, 104–109.
Monge, M., et al., 2013. A fully intraocular high-density self-
calibrating epiretinal prosthesis. IEEE Trans. Biomed. Circuits
Syst. 7, 747–760.
Morillas, C., et al., 2007. A neuroengineering suite of
computational tools for visual prostheses. Neurocomputing
70, 2817–2827.
Mullen, K.T., Dumoulin, S.O., Hess, R.F., 2008. Color responses of
the human lateral geniculate nucleus: selective amplification
of S-cone signals between the lateral geniculate nucleno and
primary visual cortex measured with high-field fMRI. Eur. J.
Neurosci. 28, 1911–1923.
Musa, S., et al., 2012. Bottom-up SiO2 embedded carbon nanotube
electrodes with superior performance for integration in
implantable neural microsystems. ACS Nano 6, 4615–4628.
National Institute on Deafness and Other Communication
Disorders, 2013. Cochlear Implants (NIH Publication no. 11-
4798). NIDCD Information Clearing House, Bethesda, MD.
Naumann, J., 2012. In: Search for Paradise: A Patient’s Account of
the Artificial Vision Experiment. XLIBRIS Corporation,
Bloomington, IN, USA.
Negi, S., et al., 2010. Neural electrode degradation from
continuous electrical stimulation: comparison of sputtered
and activated iridium oxide. J. Neurosci. Methods 186, 8–17.
Negi, S., Bhandari, R., Solzbacher, F., 2012. A novel technique for
increasing charge injection capacity of neural electrodes for
efficacious and safe neural stimulation. Conf. Proc. IEEE Eng.
Med. Biol. Soc. 2012, 5142–5145.
Ng, D.C., et al., 2011. Wireless power delivery for retinal
prostheses. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2011,
8356–8360.
Nicolelis, M.A., et al., 2003. Chronic, multisite, multielectrode
recordings in macaque monkeys. Proc. Natl. Acad. Sci. USA
100, 11041–11046.
Normann, R.A., et al., 2009. Toward the development of a cortically
based visual neuroprosthesis. J. Neural Eng. 6, 035001.
O’Brien Jr., W.D., et al., 2008. The risk of exposure to diagnostic
ultrasound in postnatal subjects: thermal effects. J.
Ultrasound Med. 27, 517–535 (quiz 537–540).
O’Doherty, J.E., et al., 2011. Active tactile exploration using a
brain-machine–brain interface. Nature 479, 228–231.
Ong, J.M., da Cruz, L., 2012. The bionic eye: a review. Clin. Exp.
Ophthalmol. 40, 6–17.
Ortmann, V., Baziyan, B., 2007. Intracortical neural interface for
prosthetic applications. Conf. Proc. IEEE Eng. Med. Biol. Soc.
2007, 6372–6375.
Panetsos, F., et al., 2011. Consistent phosphenes generated by
electrical microstimulation of the visual thalamus. An
experimental approach for thalamic visual neuroprostheses.
Front. Neurosci. 5, 84.
Paralikar, K.J., Clement, R.S., 2008. Collagenase-aided intracortical
microelectrode array insertion: effects on insertion force and
recording performance. IEEE Trans. Biomed. Eng. 55,
2258–2267.
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 372Parikh, N., et al., 2013. Performance of visually guided tasks using
simulated prosthetic vision and saliency-based cues. J. Neural
Eng. 10, 026017.
Parker, R.A., et al., 2011. The functional consequences of chronic,
physiologically effective intracortical microstimulation. Prog.
Brain Res. 194, 145–165.
Parker, S.L., et al., 2014. Cost savings associated with antibiotic-
impregnated shunt catheters in the treatment of adult and
pediatric hydrocephalus. World Neurosurg..
Pascolini, D., Mariotti, S.P., 2012. Global estimates of visual
impairment: 2010. Br. J. Ophthalmol. 96, 614–618.
Pearson, R.A., 2014. Advances in repairing the degenerate retina by
rod photoreceptor transplantation. Biotechnol. Adv. 32, 485–491.
Penfield, W., 1947. Some observations on the cerebral cortex of
man. Proc. R. Soc. Lond. B Biol. Sci. 134, 329–347.
Peters, T., et al., 2013. Emotional wellbeing of blind patients in a
pilot trial with subretinal implants. Graefes Arch. Clin. Exp.
Ophthalmol. 251, 1489–1493.
Petrs-Silva, H., Linden, R., 2014. Advances in gene therapy
technologies to treat retinitis pigmentosa. Clin. Ophthalmol.
8, 127–136.
Pezaris, J.S., Reid, R.C., 2007. Demonstration of artificial visual
percepts generated through thalamic microstimulation. Proc.
Natl. Acad. Sci. USA 104, 7670–7675.
Pezaris, J.S., Eskandar, E.N., 2009. Getting signals into the brain:
visual prosthetics through thalamic microstimulation.
Neurosurg. Focus. 27, E6.
Plow, E.B., Pascual-Leone, A., Machado, A., 2012. Brain stimulation
in the treatment of chronic neuropathic and non-cancerous
pain. J. Pain 13, 411–424.
Poggio, G.F., Walker, A.E., Andy, O.J., 1956. The propagation of
cortical after-discharge through subcortical structures. AMA
Arch. Neurol. Psychiatry 75, 350–361.
Polikov, V.S., Tresco, P.A., Reichert, W.M., 2005. Response of brain
tissue to chronically implanted neural electrodes. J. Neurosci.
Methods 148, 1–18.
Pollen, D.A., 1975. Some perceptual effects of electrical
stimulation of the visual cortex in man. In: Tower, D.B. (Ed.),
The Nervous System, Vol. 2: The Clinical Neurosciences, vol. 2.
Raven Press, New York, pp. 519–528.
Pollen, D.A., 1977. Responses of single neurons to electrical
stimulation of the surface of the visual cortex. Brain Behav.
Evol. 14, 67–86.
Ptito, M., et al., 2008a. TMS of the occipital cortex induces tactile
sensations in the fingers of blind Braille readers. Exp. Brain
Res. 184, 193–200.
Ptito, M., et al., 2008b. Alterations of the visual pathways in
congenital blindness. Exp. Brain Res. 187, 41–49.
Pudenz, R.H., 1993. Neural stimulation: clinical and laboratory
experiences. Surg. Neurol. 39, 235–242.
Qin, W., et al., 2013. The development of visual areas depends
differently on visual experience. PLoS One 8, e53784.
Rasouli, M., Phee, L.S., 2010. Energy sources and their
development for application in medical devices. Expert Rev.
Med. Dev. 7, 693–709.
Reich, L., Maidenbaum, S., Amedi, A., 2012. The brain as a flexible
task machine: implications for visual rehabilitation using
noninvasive vs. invasive approaches. Curr. Opin. Neurol. 25,
86–95.
Rennaker, R.L., et al., 2005. A comparison of chronic multi-
channel cortical implantation techniques: manual versus
mechanical insertion. J. Neurosci. Methods 142, 169–176.
Rieck, J., 2013. The pathogenesis of glaucoma in the interplay
with the immune system. Invest. Ophthalmol. Vis. Sci. 54,
2393–2409.
Rizzo, J.F., Ayton, L.N., 2014. Psychophysical testing of visual
prosthetic devices: a call to establish a multi-national joint
task force. J. Neural Eng. 11, 020301.Rousche, P.J., Normann, R.A., 1992. A method for pneumatically
inserting an array of penetrating electrodes into cortical
tissue. Ann. Biomed. Eng. 20, 413–422.
Rousche, P.J., Normann, R.A., 1998. Chronic recording capability of
the Utah Intracortical Electrode Array in cat sensory cortex.
J. Neurosci. Methods 82, 1–15.
Rush, A., Sungjae, S., Troyk, P.R., 2011. An inductive link for an
intracortical visual prosthesis. In: 5th International IEEE/EMBS
Conference on Neural Engineering (NER), 2011, pp. 503–506.
Rushton, D.N., Brindley, G.S., 1977. Short- and long-term stability
of cortical electrical phosphenes. In: Rose, F.C. (Ed.),
Physiological Aspects of Clinical Neurology. Blackwell
Scientific Publications, Oxford, pp. 123–153.
Rushton, D.N., et al., 1989. Implant infections and antibiotic-
impregnated silicone rubber coating. J. Neurol. Neurosurg.
Psychiatry 52, 223–229.
Sakaguchi, H., et al., 2009. Artificial vision by direct optic nerve
electrode (AV-DONE) implantation in a blind patient with
retinitis pigmentosa. J. Artif. Organs 12, 206–209.
Salt, T.E., Tulloch, I.F., Walter, D.S., 1980. Anti-epileptic properties
of sodium valproate in rat amygdaloid kindling [proceedings].
Br. J. Pharmacol. 68, 134P.
Sanni, A., Vilches, A., Toumazou, C., 2012. Inductive and
ultrasonic multi-tier interface for low-power, deeply
implantable medical devices. IEEE Trans. Biomed. Circuits
Syst. 6, 297–308.
Schmidt, E.M., Bak, M.J., McIntosh, J.S., 1976. Long-term chronic
recording from cortical neurons. Exp. Neurol. 52, 496–506.
Schmidt, E.M., et al., 1996. Feasibility of a visual prosthesis for the
blind based on intracortical microstimulation of the visual
cortex. Brain 119 (Pt 2), 507–522.
Schneider, R.M., et al., 2013. Neurological basis for eye
movements of the blind. PLoS One 8, e56556.
Schoth, F., et al., 2006. Diffusion tensor imaging in acquired blind
humans. Neurosci. Lett. 398, 178–182.
Seifman, M.A., et al., 2011. Postoperative intracranial
haemorrhage: a review. Neurosurg. Rev. 34, 393–407.
Seymour, J.P., Kipke, D.R., 2007. Neural probe design for reduced
tissue encapsulation in CNS. Biomaterials 28, 3594–3607.
Shain, W., et al., 2003. Controlling cellular reactive responses
around neural prosthetic devices using peripheral and local
intervention strategies. IEEE Trans. Neural Syst. Rehabil. Eng.
11, 186–188.
Sharma, A., et al., 2011. Long term in vitro functional stability and
recording longevity of fully integrated wireless neural
interfaces based on the Utah Slant Electrode Array. J. Neural
Eng. 8, 045004.
Shaw, J.E., Sicree, R.A., Zimmet, P.Z., 2010. Global estimates of the
prevalence of diabetes for 2010 and 2030. Diabet. Res. Clin.
Pract. 87, 4–14.
Shepherd, R.K., et al., 2013. Visual prostheses for the blind.
Trends Biotechnol. 31, 562–571.
Simard, G., Sawan, M., Massicotte, D., 2010. High-speed OQPSK
and efficient power transfer through inductive link for
biomedical implants. IEEE Trans. Biomed. Circuits Syst. 4,
192–200.
Skousen, J.L., et al., 2011. Reducing surface area while
maintaining implant penetrating profile lowers the brain
foreign body response to chronically implanted planar silicon
microelectrode arrays. Prog. Brain Res. 194, 167–180.
Srivastava, N.R., et al., 2007. Estimating Phosphene Maps for
Psychophysical Experiments used in Testing a Cortical Visual
Prosthesis Device. In: 3rd International IEEE/EMBS Conference
on Neural Engineering, 2007. CNE’07, pp. 130–133.
Srivastava, N.R., Troyk, P.R., Dagnelie, G., 2009. Detection, eye-
hand coordination and virtual mobility performance in
simulated vision for a cortical visual prosthesis device.
J. Neural Eng. 6, 035008.
b r a i n r e s e a r c h 1 5 9 5 ( 2 0 1 5 ) 5 1 – 7 3 73Stensaas, S.S., Eddington, D.K., Dobelle, W.H., 1974. The
topography and variability of the primary visual cortex in
man. J. Neurosurg. 40, 747–755.
Stevens, G.A., et al., 2013. Global prevalence of vision impairment
and blindness: magnitude and temporal trends, 1990–2010.
Ophthalmology 120, 2377–2384.
Stingl, K., et al., 2013. Artificial vision with wirelessly powered
subretinal electronic implant alpha-IMS. Proc. Biol. Sci. 280,
20130077.
Stronks, H.C., Dagnelie, G., 2011. Phosphene mapping techniques
for visual prostheses. In: Dagnelie, G. (Ed.), Visual Prosthetics:
Physiology, Bioengineering, Rehabilitation. Springer, New
York, pp. 367–383.
Szarowski, D.H., et al., 2003. Brain responses to micro-machined
silicon devices. Brain Res. 983, 23–35.
Tabot, G.A., et al., 2013. Restoring the sense of touch with a
prosthetic hand through a brain interface. Proc. Natl. Acad.
Sci. USA 110, 18279–18284.
Talalla, A., Bullara, L., Pudenz, R., 1974. Electrical stimulation of
the human visual cortex; preliminary report. Can. J. Neurol.
Sci. 1, 236–238.
Taylor, H.R., et al., 2005. Vision loss in Australia. Med. J. Aust. 182,
565–568.
Taylor, H.R., Pezzullo, M.L., Keeffe, J.E., 2006. The economic
impact and cost of visual impairment in Australia. Br. J.
Ophthalmol. 90, 272–275.
Taylor, I., Scheffer, I.E., Berkovic, S.F., 2003. Occipital epilepsies:
identification of specific and newly recognized syndromes.
Brain 126, 753–769.
Tehovnik, E.J., Slocum, W.M., Schiller, P.H., 2003. Saccadic eye
movements evoked by microstimulation of striate cortex.
Eur. J. Neurosci. 17, 870–878.
Tehovnik, E.J., Slocum, W.M., 2013. Electrical induction of vision.
Neurosci. Biobehav. Rev. 37, 803–818.
Theogarajan, L., 2012. Strategies for restoring vision to the blind:
current and emerging technologies. Neurosci. Lett. 519, 129–133.
Torab, K., et al., 2011. Multiple factors may influence the
performance of a visual prosthesis based on intracortical
microstimulation: nonhuman primate behavioural
experimentation. J. Neural Eng. 8, 035001.
Troncoso, X.G., Macknik, S.L., Martinez-Conde, S., 2011. Vision’s
first steps: anatomy, physiology, and perception in the retina,
lateral geniculate nucleus, and early visual cortical areas. In:
Dagnelie, G. (Ed.), Visual Prosthetics. Springer, US, pp. 23–57.
Troyk, P.R., et al., 2005. Intracortical visual prosthesis research –
approach and progress. In: Proceedings of 27th Annual
International Conference of the IEEE EMBS. Shanghai, China,
September 1–4, 2005, pp. 7376–7379.
Veraart, C., et al., 1998. Visual sensations produced by optic nerve
stimulation using an implanted self-sizing spiral cuff
electrode. Brain Res. 813, 181–186.
Veraart, C., et al., 2003. Pattern recognition with the optic nerve
visual prosthesis. Artif. Organs 27, 996–1004.
Volta, A., 1800. On the electricity excited by the mere contact of
conducting substances of different kinds. Philos. Trans. R. Soc.
Lond. 90, 403–431.
Wada, Y., et al., 1989. Kindling of the visual cortex in cats:
comparison with amygdaloid kindling. Jpn. J. Psychiatry
Neurol. 43, 245–253.
Wada, Y., et al., 1990. Anticonvulsant effects of zonisamide and
phenytoin on seizure activity of the feline visual cortex. Brain
Dev. 12, 206–210.
Walcott, B.P., Redjal, N., Coumans, J.V., 2012. Infection following
operations on the central nervous system: deconstructing the
myth of the sterile field. Neurosurg. Focus. 33, E8.Wang, C., et al., 2013. Characteristics of electrode impedance and
stimulation efficacy of a chronic cortical implant using novel
annulus electrodes in rat motor cortex. J. Neural Eng. 10,
046010.
Wark, H.A., et al., 2013. A new high-density (25 electrodes/mm(2))
penetrating microelectrode array for recording and
stimulating sub-millimeter neuroanatomical structures.
J. Neural Eng. 10, 045003.
Waziri, A., et al., 2009. Initial surgical experience with a dense
cortical microarray in epileptic patients undergoing
craniotomy for subdural electrode implantation.
Neurosurgery 64, 540–545 (discussion 545).
Weiland, J.D., Humayun, M.S., 2014. Retinal prosthesis. IEEE
Trans. Biomed. Eng. 61, 1412–1424.
Weiss, N., Post, K.D., 2011. Avoidance of complications in
neurosurgery. In: 6th edition In: Winn, H.R. (Ed.), Youmans
Neurological Surgery, vol. 1. Saunders, St. Louis, MO, USA, pp.
408–423.
Wiesel, T.N., Hubel, D.H., 1966. Spatial and chromatic interactions
in the lateral geniculate body of the rhesus monkey.
J. Neurophysiol. 29, 1115–1156.
Wilke, R., et al., 2007. Testing visual functions in patients with
visual prostheses. In: Humayun, M.S., Weiland, J.D., Chader,
G., Greenbaum, E. (Eds.), Artificial Sight. Biological and
Medical Physics, Biomedical Engineering. Springer, New York,
pp. 91–110.
Wilks, S.J., et al., 2009. Poly(3,4-ethylenedioxythiophene) as a
micro-neural interface material for electrostimulation. Front.
Neuroeng. 2, 7.
Williams, N.R., Okun, M.S., 2013. Deep brain stimulation (DBS) at
the interface of neurology and psychiatry. J. Clin. Invest. 123,
4546–4556.
Wong, C.H., et al., 2009. Risk factors for complications during
intracranial electrode recording in presurgical evaluation of
drug resistant partial epilepsy. Acta Neurochir. (Wien) 151,
37–50.
Wu, K.J., et al., 2010. Current research of C-Sight visual prosthesis
for the blind. In: Proceedings of 2010 Annual International
Conference of the IEEE Engineering in Medicine and Biology
Society (EMBC), pp. 5875–5878.
Yablonskiy, D.A., Ackerman, J.J., Raichle, M.E., 2000. Coupling
between changes in human brain temperature and oxidative
metabolism during prolonged visual stimulation. Proc. Natl.
Acad. Sci. USA 97, 7603–7608.
Yamamoto, J., Wilson, M.A., 2008. Large-scale chronically
implantable precision motorized microdrive array for freely
behaving animals. J. Neurophysiol. 100, 2430–2440.
Yanai, D., et al., 2003. The value of preoperative tests in the
selection of blind patients for a permanent microelectronic
implant. Trans. Am. Ophthalmol. Soc. 101, 223–228 (discussion
228–230).
Yang, S., et al., 2010. Highly-accurate, implantable
micromanipulator for single neuron recordings. In:
Proceedings of 2010 IEEE International Conference on Robotics
and Automation (ICRA), pp. 5070–5075.
Zarbin, M.A., et al., 2013. Nanomedicine for the treatment of
retinal and optic nerve diseases. Curr. Opin. Pharmacol. 13,
134–148.
Zhang, Y., et al., 2012. Diffusion tensor imaging reveals normal
geniculocalcarine-tract integrity in acquired blindness. Brain
Res. 1458, 34–39.
Zhong, Y., Bellamkonda, R.V., 2007. Dexamethasone-coated
neural probes elicit attenuated inflammatory response and
neuronal loss compared to uncoated neural probes. Brain Res.
1148, 15–27.
